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There is nothing permanent except change.
Heraclitus

Abstract
Influenzaviren müssen in die Wirtszelle aufgenommen werden, um dort ihr Genom freizuset-
zen und ihre Replikation mit Hilfe des Reproduktionsapparats der Zelle einzuleiten. Der
komplexe Replikationszyklus der Influenza A Viren ist noch nicht vollständig verstanden.
Er beginnt mit der Bindung des viralen Hämagglutinins (HA) an Sialinsäure (SA) auf der
Zelloberfläche der Wirtszelle. Diese Bindung besitzt eine Dissoziationskonstante im un-
teren millimolaren Bereich (Sauter et al., 1992). In dieser Arbeit wurde die Bindungskraft
zwischen Influenza A Viren und Zellen auf der Ebene einzelner Moleküle untersucht. Die
Messung der Bindung von Viren an lebende Zellen mittels Einzelviruskraftspektroskopie
ist dabei der natürlichen Situation sehr ähnlich.
In dieser Arbeit wurde die Bindung an Zellen mit unterschiedlicher Rezeptorkomposi-
tion verglichen. Dabei konnte gezeigt werden, dass für die zelluläre Spezifität die Präsen-
tation des Rezeptors innerhalb der Plasmamembran der Zelle eine größere Rolle spielt
als die Struktur des Rezeptorglykans selbst. Des Weiteren deuten die Beobachtung sehr
kleiner Kräfte und ein stufenweises Öffnen von Bindungen auf eine multivalente Interak-
tion hin. Multivalenz wird oft in biologischen Bindungsprozessen beobachtet und kann
Bindungskräfte enorm verstärken. Die hier durchgeführten Kraftmessungen beschreiben
eine sehr dynamische Interaktion, die maßgeblich von der terminalen Sialinsäure bestimmt
wird. Basierend auf diesen Ergebnissen wurden inhibitorische Nanopartikel entwickelt, die
die natürliche Zelloberfläche als hochaffine Bindungsalternative imitieren. Verschiedenar-
tige Nanopartikel wurden evaluiert und konnten die Virusaktivität um mehr als 80 % hem-
men. Da über die Details multivalenter Interaktionen wenig bekannt ist, wurden Parameter
wie Abstand und Präsentation der Liganden variiert. Es konnte gezeigt werden, dass die
Virusinhibition durch Nanopartikel entscheidend von der Dichte der Liganden und der Par-
tikelgröße abhängt.
Nach der Bindung wird das Virus durch Endozytose in die Zelle aufgenommen. Durch
spezifische Virusmarkierung und gleichzeitiger Expression von zellulären Markerproteinen
wurde der Transport einzelner Viren in lebenden Zellen verfolgt. Dabei konnte gezeigt
werden, dass das Virus sowohl durch frühe, als auch durch späte Endosomen wandern
muss, um sein Genom erfolgreich in das Zytoplasma zu entlassen. Außerdem verzögert
das Virus die endosomale Ansäuerung um eine optimale Aufenthaltsdauer im Endosom
und die lokalisierte Fusion in der Nähe des Zellkerns zu gewährleisten. Pharmakologisches
Eingreifen in diese Prozesse konnte zudem weitere kritische Faktoren identifizieren, die die
Effizienz der Virusinfektion stark beeinflussen.
Zusammengenommen zeichnen die Ergebnisse dieser Arbeit ein detailliertes Bild der
initialen Phase der Virusinfektion. Aufbauend auf den initialen Ergebnissen, konnten in-
hibitorische Nanopartikel konstruiert werden, die spezifisch die Aktivität des Influenza A
Virus hemmen. Diese Arbeit kann damit als Basis für gezielte antivirale Strategien dienen
und dazu beitragen, die Virusinfektion bereits in der initialen Phase zu blockieren.
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Abstract
Influenza virus must enter a host cell to deliver its genome, use the cells reproductive
machinery and eventually initiate its replication. The replication cycle of influenza A virus
is very complex and still not fully understood. It generally starts with binding of the vi-
ral protein hemagglutinin (HA) to its cellular receptor sialic acid (SA), a process that was
shown to have dissociation constants in the millimolar range (Sauter et al., 1992). However,
virus-cell binding is much more complex.
In this work, virus-cell attachment forces were investigated at the single molecule level
using intact virus binding to living cells, a set-up that closely mimics the in vivo situation.
Cells of different surface SA composition were compared. It could be shown that the unique
presentation of the ligand within the cells plasma membrane, rather than the structure of the
receptor-glycan itself, strongly affects cellular specificity. The low binding force as well as
the observation of stepwise unbinding events suggest a multivalent interaction type.
Multivalency is ubiquitous in biological processes and can enormously enhance binding
strength. Force measurements revealed this interaction as very dynamic and mostly depends
on a terminal sialic acid moiety. Based on this finding, inhibitory nanoparticles mimicking
the cell surface were constructed. Those particles serve as a high-affinity alternative for
the virus to bind. Different particles were evaluated and shown to efficiently inhibit virus
infection by 80 %. However, many of the molecular details of multivalent interactions
remain poorly understood. Hence, parameters such as ligand spacing and presentation were
varied and revealed that the density of ligands as well as the interacting surface play critical
roles for virus inhibition.
Upon attachment, the virus enters the cell by endocytosis. Virus trafficking was followed
at the single-virus level in living cells. The kinetics of virus transport were visualized using
fluorescent marker proteins in combination with specific virus labeling. It was found that
the virus needs to progress through early and late endosomal compartments in order to effi-
ciently uncoat and release its genome. Further, the virus delays the endosomal acidification
to ensure optimal residence time and fusion in the region close to the host cell nucleus.
Drug treatment furthermore unraveled critical factors influencing viral infection efficiency.
Taken together, the presented results provide a detailed picture of the initial phase of
influenza A virus infection. These were used to construct inhibitory nanoparticles, that can
specifically inhibit virus activity. The results of this thesis further serve as the basis for
targeted antiviral strategies that can block the virus during the initial steps of infection.
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1 Introduction
1.1 The biology of influenza A virus
The spread and evolution of influenza viruses worldwide is monitored by the Global Influenza
Surveillance and Response System (GISRS) created by the World Health Organization (WHO).
The backbone of GISRS is formed by a worldwide network of national influenza centers. In Ger-
many, the Robert Koch-Institute (RKI) is the national reference center for influenza and other
respiratory diseases.
As the RKI reported, in the season of 2011/2012 influenza A viruses were detected in 9.500
patients in Germany (RKI, Saisonbericht 2011/12). For comparison, in the preceding season
of 2010/11, 41.000 diagnosed infections were recorded due to the pandemic “swine flu” virus
(RKI, Saisonbericht 2010/11). On average, influenza and accompanying infections can cause
up to 11.000 fatalities per year in Germany (RKI, Saisonbericht 2009/10). In 2011, a study
coordinated by the RKI introduced a priority ranking of human pathogens according to their im-
portance for national surveillance and epidemiological research (Balabanova et al., 2011). Here,
the case fatality rate was the most important criterion and influenza virus was ranked within the
highest priority group.
Influenza A viruses have been circulating in the human population since at least 96 years, when
the so far most devastating pandemic spread around the world. Between what is now known
as the Spanish flu in 1918 and the most recent swine flu pandemic from 2009, another three
major influenza pandemics circulated among the human population. Only two years after the
appearance of the pandemic influenza virus in Mexico, another new influenza variant appeared
in July 2011 in the United States (WHO). This virus has a new genetic composition: most of
its genes derived from viruses circulating in pigs while one originated from the 2009 pandemic
virus. Interestingly, this virus spreads from pigs into humans but only rarely between humans.
The bird flu (H5N1) appeared in 1996 and since then received a lot of public attention due to
its high pandemic potential (Watanabe et al., 2012). The virus does not readily transmit from
human to human and can directly infect humans only through close contact with contaminated
birds. Two highly controversial studies experimentally achieved direct transmission after adapt-
ing the virus in ferrets (Imai et al., 2012; Herfst et al., 2012). However, publication of these data
1
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sparked a worldwide discussion about biosafety laws and led to an agreed moratorium on H5N1
research (Fouchier et al., 2012).
These examples highlight the significance of influenza virus as a human pathogen. Since its
discovery in 1933, the virus has lost nothing of its fascination and despite decades of scientific
investigations only recently, state-of-the-art methods permit studying virus biology at entirely
new levels.
1.1.1 Virus structure and morphology
Hemagglutinin
Neuraminidase
H-Channel M2
Matrix Protein M1
vRNP
A
C
B
D
NP
vRNA
PB1
PB2
PA
Figure 1.1: EM micrographs and schematic representation of influenza A viruses. Influenza A/X-
31 viruses are very pleiomorph, but grown on chicken eggs preferentially form spherical particles that
are 100-150 nm in diameter (A). Depending on the M1/M2 genes and the used propagation method, the
virus can form filaments of up to several micrometer (C). Schematic representation of influenza A virus
(B) and a viral ribonucleoprotein complex (vRNP) (D). PB1, PB2 and PA are subunits of the viral RNA
dependent RNA polymerase complex. NP, nucleoprotein. EM micrographs were kindly provided by Dr.
Kai Ludwig, Research Center of Electron Microscopy, Freie Universität Berlin. Scale bar: 100 nm.
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Influenza A virus proteins
Influenza A viruses belong to the family of Orthomyxoviridae. They are encapsulated by a lipid
bilayer and are therefore subcategorized into the group of enveloped viruses (Bouvier and Palese,
2008). The envelope harbors the two glycoproteins hemagglutinin (HA) and neuraminidase
(NA) as well as the tetrameric proton channel M2 (Webster et al., 1992) (Fig. 1.1). Because of
their shape, HA and NA are often referred to as spike proteins. Antigenic differences in HA and
NA are used to classify influenza A viruses into 17 HA (H) and 9 NA (N) subtypes (Medina and
García-Sastre, 2011; Tong et al., 2012). The most recent H17 subtype was identified in bats in
2012 (Tong et al., 2012).
Underneath the lipid bilayer is a layer of the matrix protein M1 (Fig. 1.1 B). The genome
of influenza A viruses is composed of eight segments of single-stranded, negative-sense RNA
(vRNA). Genomic vRNA is packed with four proteins PB1, PB2, PA and the nucleoprotein NP
to form eight ribonucleoprotein complexes (vRNPs) (Fig. 1.1 D). PB1, PB2 and PA are subunits
of the viral RNA dependent RNA polymerase complex. All influenza A virus proteins and their
function are summarized in Table 1.1. HA is discussed in more detail in section 1.1.3.
Table 1.1: Proteins of influenza A viruses. From (Lamb and Krug, 1996) AA, amino acids; Nt, nu-
cleotides
genome protein length AA copies function
segment name (Nt) (kDa) per virus
1 PB2 2341 759 (86) 45 viral polymerase subunit
2 PB1
PB1-F2
2341 757 (86)
87 (10)
45 viral polymerase subunit
induction of apoptosis
3 PA 2233 716 (80) 45 viral polymerase subunit
4 HA 1778 566 (65) 1200 receptor binding
membrane fusion
5 NP 1565 498 (56) 1000 genome packaging
vRNP nuclear import
6 NA 1413 454 (55) 400 neuraminidase
7 M1
M2
1027 252 (28)
97 (15)
3000
97
matrix, assembly
proton channel
8 NS1
NS2
(NEP)
890 230 (26)
121 (11)
-
160
interferon antagonist
vRNP nuclear export
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1.1.2 Replication cycle of influenza A virus
An overview of the influenza virus replication cycle is presented in Fig. 1.2.
Cell binding and entry
Viruses, being obligate intracellular organisms, must enter cells to replicate while using the
cell s synthesis machinery. HA mediates virus-cell attachment by binding to terminal sialic acid
(SA) residues on glycoproteins and -lipids within the plasma membrane. After binding, the
virus enters the cell by endocytosis. Clathrin-mediated endocytosis (CME) is one of the best
characterized entry pathways used by numerous viruses (Marsh and Helenius, 2006; Mercer
et al., 2010). In 1981, influenza viruses were observed for the first time in coated vesicles,
indicating uptake by CME (Matlin et al., 1981). However, in the same study the virus was also
observed in smooth invaginations and vesicles, suggesting an alternative entry pathway. CME
is often triggered by binding or clustering of specific cellular receptors (McMahon and Boucrot,
2011). In the case of influenza A virus, the actual trigger is not known. It was shown that
epidermal growth factor (EGF) promotes entry (Eierhoff et al., 2010) and that the virus can use
pre-existing clathrin-coated pits (CCP) or promote their de novo formation (Rust et al., 2004).
These results suggest the requirement of post-attachment factors that trigger endocytosis after
SA binding. In 2002, influenza A virus infection was also shown to occur independently of
caveolin- and clathrin-mediated endocytosis (Sieczkarski and Whittaker, 2002a). In two recent
papers, macropinocytosis was shown as an alternative entry pathway (Rossman et al., 2012;
de Vries et al., 2011), particularly important for long filamentous viruses (Rossman et al., 2012).
Endosomal maturation and fusion
After endocytosis, the virus-containing vesicle is transported and fuses with early endosomes
(EE) (Huotari and Helenius, 2011; Lozach et al., 2011) (Fig. 1.3). This transport was shown to
depend on cortical actin (Lakadamyali et al., 2003). EEs function as a sorting site with specific
domains. Some of these domains form recycling endosomes or vesicles maturing towards the
late endosomal / lysosomal pathway. The combination of processes that lead to the formation
of late endosomes / lysosomes is summarized as endosomal maturation. Important hallmarks of
endosomal maturation are (1) a switch of associated small Rab GTPases and (2) an acidification
of the endosomal lumen (Huotari and Helenius, 2011). Rab5 primarily associates with the EE
and was shown to be a key organizer of the endocytic system which is thus extremely sensitive
to Rab5 depletion (Zeigerer et al., 2012). Rab5 and its effectors are replaced by Rab7 and
accompanying proteins during maturation (Huotari and Helenius, 2011). Two mechanisms were
reported to facilitate the transport of cargo from early to late endosomes. One was observed
4
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mRNA synthesis
ŐĞŶŽŵĞƌĞƉůŝĐĂƟŽŶ
Golgi
Endosome Nucleus
ER
early proteins
PA
PB1
PB2
PB1-F2
NP
NS1
mRNA
late proteins
mRNA
M1
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vRNP
genome
Figure 1.2: Replication cycle of influenza A virus. The virus binds to sialic acid residues on the cell
surface and enters the cell by endocytosis. Clathrin-mediated endcytosis as well as macropinocytosis
are described as entry pathways. The low pH in maturing or late endosomes triggers a conformational
change of HA mediating fusion of viral envelope and endosomal membrane. The released genome in
form of eight vRNPs translocates into the nucleus, where mRNA as well as vRNA synthesis take place.
Viral proteins are translated in the cytoplasm (early proteins) or on ER-bound ribosomes (transmembrane
proteins) and transported back into the nucleus or towards the plasma membrane. New viral proteins
(PB1, PB2, PA, NP) assemble progeny vRNPs in the nucleus, which are exported by the help of M1 and
NS2 and transferred to the budding site. The virus buds presumably by a concerted interaction of the
spike proteins and M1 and is finally released by M2-mediated membrane scission.
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for semliki forrest virus (SFV) and proposes that early and late endosomes are rather static and
vesicles facilitate transport from one to the other (Vonderheit and Helenius, 2005). The second
model proposes a conversion of Rab proteins as the trigger of maturation into LE. Specific
regulators, the first SAND1/Mon1 was identified in C.elegans, control this process (Rink et al.,
2005).
EE
pH 6.5-6 5.5-5
LE
Rab7
Rab5
nucleus
microtubules
actin
Figure 1.3: Endocytic trafficking of influenza A virus. Influenza A virus is internalized into vesi-
cles, which are transported towards and fuse with early endosomes (EE). EE are regulated by associated
Rab5 GTPases (magenta), typical markers for these compartments. In the course of maturation the endo-
somes are acidified by membrane bound V-type proton ATPases. In addition, Rab5 and its effectors are
exchanged for Rab7 (green), which decorates late endosomes (LE). The endosomes travel along micro-
tubules mediated by the motor protein dynein. When the pH decreases, the virus fuses and its genome is
released into the cytoplasm.
A low intravesicular pH is important for protein sorting and degradation, activity of hydrolytic
enzymes as well as inactivation of pathogens. It is mainly regulated by the number of V-type
ATPases within the endosomal membrane. The pH values of the corresponding compartments
are illustrated in Figure 1.3. Influenza viruses were shown to be transported along microtubules
within endosomal vesicles (Rust et al., 2004; Lakadamyali et al., 2006, 2003) and that this trans-
port occurs before and after virus-containing endosomes co-localize with early endosomal com-
partments (Lakadamyali et al., 2006, 2003). The vesicles typically travel towards the perinuclear
region (PNR) similar to ligands bound for degradation. The pH decrease within the endosome
triggers a conformational change of the viral HA, eventually leading to fusion of the endosomal
membrane with the viral envelope.
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Viral protein synthesis and virus assembly.
During endosomal maturation the viral M2 proton channel acidifies the virus lumen, which is
thought to promote dissociation of M1 from vRNPs (Martin and Helenius, 1991b; Helenius,
1992a). Indeed, it was shown that import of vRNPs into the nucleus depends on the action of
M2 and is sensitive to the M2 inhibitor amantadine (Martin and Helenius, 1991b). Cytosolic
vRNPs quickly translocate into the nucleus (Babcock et al., 2004), a process that is mediated
by a nuclear localization sequence (NLS) within NP interacting with importin (Portela and
Digard, 2002). Inside the nucleus, the viral RNA polymerase (PA) initiates synthesis of viral
mRNA (+ stranded) as well as replication of the viral RNA (- stranded). At first, the viral PB2
binds host mRNAs while PA cleaves 10-13 bases downstream of the 5 -cap (cap snatching). This
small fragment (m7 GpppG) is used by PB1 as a primer to synthesize viral mRNA (Steinhauer
and Skehel, 2002). vRNA is produced using a copy RNA intermediate which is neither capped
nor polyadenylated and corresponds to the full vRNA complement. The switch from transcrip-
tion to replication is not fully understood. The accumulation of viral NP and small virus-derived
RNAs (Perez et al., 2010) were previously suggested to be involved.
NS1, NP and the polymerase subunits are the first synthesized proteins (Shapiro et al., 1987).
The transmembrane proteins HA, NA and M2 are later translated by membrane-bound ribo-
somes into the ER. Hence, the proteins enter the secretory pathway including post-translational
protein modification in the Golgi apparatus and further transport to the plasmamembrane (Copeland
et al., 1986, 1988). The polymerase proteins NP and vRNA form new vRNP complexes which
are exported from the nucleus with the help of NS2 and M1 (Portela and Digard, 2002). Re-
cently, it was shown that newly synthesized vRNPs accumulate at the microtubule organization
center (MTOC) after leaving the nucleus. They are then transported in Rab11-positive vesicles
along microtubules towards the cell periphery (Amorim et al., 2011). The spike proteins NA
and HA accumulate in cholesterol- and sphingolipid-enriched lipid domains (lipid rafts) (Sco-
lari et al., 2009; Kundu et al., 1996; Engel et al., 2010). Here they bind M1 (Ali et al., 2000),
which as well binds to progeny vRNPs (Ye et al., 1999) and by that forms a bridge connecting
the spike proteins with the genome segments at the virus assembly site (Nayak et al., 2004). The
actual budding process is likely determined by multiple factors promoting membrane curvature
and budding. Local accumulation of HA and NA could induce membrane curvature (Stachowiak
et al., 2012). M2, one of the latest proteins expressed, is thought to stabilize the newly formed
bud and initiate scission of the fully equipped progeny virus (Rossman and Lamb, 2011; Thaa
et al., 2010).
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1.1.3 The influenza A virus hemagglutinin (HA)
HA is synthesized by membrane-bound ribosomes into the endoplasmic reticulum (ER) as a
pre-cursor protein HA0. HA0 is later cleaved into the membrane bound subunit HA2 and the
membrane distal subunit HA1 (Fig. 1.4) (Wilson et al., 1981; Skehel and Wiley, 2000). In as-
sociation with chaperones, HA0 monomers form non-covalently linked homotrimers in the ER,
which then travel through the Golgi apparatus to the plasma membrane (Copeland et al., 1986,
1988). For most HAs, the cleavage site between HA1 and HA2 (Fig. 1.4 A) is a single argi-
nine residue (monobasic cleavage site) and the precursor is cleaved by extracellular enzymes. In
some avian HAs (H5 and H7), the cleavage site is longer and contains multiple arginine residues
(polybasic cleavage site) (Horimoto and Kawaoka, 2005). In any case, cleavage generates the
highly conserved N-terminus of HA2 (residues 1-10), called the fusion peptide. The trimeric
organization of the protein is preserved during this process. Since cleavage of HA0 is manda-
tory for HAs function, more efficient cleavage at a polybasic cleavage site correlates with higher
pathogenicity.
The merger of two membranes is a thermodynamically favored process but has a high kinetic
barrier (Harrison, 2008). Low pH treatment of HA leads to an irreversible conformational
change (Skehel and Wiley, 2000, 2002), forming the so-called post-fusion or low-pH confor-
mation of HA and supplying the energy needed for membrane fusion. The fusion protein HA
itself needs an activation, under native conditions in the form of proton binding. The activation
can also be triggered by high temperature or a strong denaturant like urea (Carr et al., 1997).
This means that HA, and consequently the whole virus, is intrinsically metastable, a hallmark of
all viruses.
The conformational change of HA can be divided into three steps (Fig.1.4C). (1) Protonation of
HA1 leads to dissociation of intratrimeric contacts and allows water to enter the central cavity
of the trimer (Böttcher et al., 1999; Huang et al., 2003). (2) The top loop of the HA2 N-terminus
undergoes a loop-to-helix transition resulting in an extended coiled-coil conformation of the
three monomers (extended intermediate). The coils contain hydrophobic and hydrophilic amino
acids in a repetitive manner, forming a heptad pattern (heptad repeats, Carr and Kim (1993)). (3)
In the C-terminal part of HA2, the extended intermediate collapses at its base and thereby draws
the fusion peptide towards the transmembrane region (Harrison, 2008). The large-scale confor-
mational change can be compared with the opening and closing of a jackknife. HA at neutral pH
is in a spring-loaded conformation, which is in line with the observation that recombinant HA2
spontaneously folds into the low-pH conformation (Carr and Kim, 1993; Chen et al., 1995).
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Figure 1.4: Structure, cleavage and conformational change of HA. HA is expressed as a precursor
HA0 (A), which is cleaved into HA1 and HA2 by Golgi-localized or extracellular proteases. The two
subunits remain connected by a disulfide linkage. The full protein assembles into a non-covalently linked
homotrimer (B, from Weis et al. (1988)). Low pH triggers a conformational change of HA. The proposed
sequence considering the two crystal structures of the neutral (a) and the low-pH form (e) is depicted
in (C). Protonation of HA1 leads to dissociation of intratrimeric contacts, which allows water to enter
the central cavity of the HA ectodomain (Böttcher et al., 1999; Huang et al., 2003). The top loop of
the HA2 N-terminus undergoes a loop-to-helix transition which results in an extended coiled-coil of the
three monomers (extended intermediate, c). In the C-terminal part of HA2, the extended intermediate
collapses and thereby draws the fusion peptide towards the transmembrane region (d). The dotted part is
not resolved in the crystal structure and corresponds to the C-terminal part of HA2 including the trans-
membrane region. SP signal peptide, FP fusion peptide, TMD transmembrane domain, CT cytoplasmic
tail.
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Receptor-binding speci city of HA
The membrane distal HA subunit (HA1) carries the receptor-binding site (RBS) recognizing
5-N-acetyl neuraminic acid (sialic acid, SA) residues on the cell surface (Fig. 1.5). The RBS is
a shallow pocket on the top of the globular head of HA1 (Weis et al., 1988). It is formed by a
number of conserved amino acid residues: among them amino acids at positions 98 (tyrosine),
153 (tryptophan), 183 (histidine), and 195 (tyrosine) form the base of the pocket. The edges are
built by three conserved elements, namely the loops 130 and 220 as well as the helix 190 (Fig.
1.5). The two major linkages between sialic acid and adjacent carbohydrates (mainly galactose)
are either of -2,3 (SA -2,3Gal) or -2,6 (SA -2,6Gal) glycosidic nature (see also 1.4.1 and
Fig. 1.7). This small difference is of great importance since different HA subtypes have different
recognition specificities for these SA linkages. In particular, avian influenza A viruses preferen-
tially bind -2,3-linked SA, while human viruses prefer to bind -2,6 linked SA (Gambaryan
et al., 1999; Matrosovich et al., 1997; Rogers et al., 1983).
Receptor binding is crucial for host specificity and supposed to be a major interspecies barrier
(Neumann et al., 2009). The preference of avian viruses to bind SA -2,3Gal matches the occur-
rence of this sugar on epithelial cells in the intestinal tract of birds, the replication site of avian
influenza viruses (Nicholls et al., 2008). In contrast, the human upper respiratory tract is rich in
SA -2,6Gal.
The receptor-binding specificity is affected by the amino acid composition of the RBS. H2 and
H3 HAs with amino acids glutamine and glycine at position 226 and 228 preferentially bind
-2,3 linked SA. A change of 226 to leucine and 228 to serine was shown to switch binding
preference towards the human type receptor (Gambaryan et al., 1999). For H1 HAs, position
190 and 225 were shown to be important (Gambaryan et al., 1999). Asparagine at both positions
confers binding to human-type receptors. Glutamine at position 190 and glycine at 225 alters
binding in favor of avian-type receptors.
1.2 Inhibition of influenza A virus infection
1.2.1 Prophylactic antiviral approach
To prevent human influenza infection, an efficient vaccine is needed. However, due to the high
variability of the viral spike proteins HA and NA, which define the antigenic phenotype, it
is difficult to produce neutralizing antibodies (Subbarao and Joseph, 2007). One approach to
circumvent this problem is to adjust the vaccine composition after every season to include new
variants. This works quite well for the seasonal influenza strains, but requires constant global
influenza infection monitoring of circulating strains. Currently, one H1N1, one H3N2 and one
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Figure 1.5: Structure of the HA receptor-binding site with bound ligands in -2,6 and -2,3 con-
formation (from Eisen et al. (1997)). Structure of one HA monomer from influenza A/X-31 bound to
lactoseries tetrasaccharide c (LSTc, -2,6 SA) (A, B) and lactoseries tetrasaccharide a (LSTa, -2,3 SA)
(C,B). The binding pocket of HA is shown in detail in (D). The main structural motifs are the base (Tyr98,
Trp153, His183, Tyr195, red) as well as the loops 130 (green) and 220 (blue).
influenza B strain are used to produce annual vaccines against seasonal influenza. The big aim
of influenza vaccine oriented science is finding neutralizing antibodies (nAbs) that target the
more conserved stem region of HA. Some recent studies have demonstrated the progress in this
area. Sui et al. (Sui et al., 2009) used recombinant HA to select non-immune human antibodies
from a phage display library and could show that the binding site is located in the stem region.
More recently, two studies have characterized broadly neutralizing antibodies (bnAb) that act on
a spectrum of influenza viruses within groups 1 and 2 (Ekiert et al., 2012; Corti et al., 2011).
However, despite the good characterization of these antibodies the main question is how to
elicit their production to sufficient titers in humans. A problem also known in the context of
prophylactic HIV vaccines (Karlsson Hedestam et al., 2008). In the following two sections
therapeutic rather than prophylactic approaches will be discussed.
1.2.2 Therapeutic antiviral approaches
Currently, only four substances are approved as anti-influenza therapeutics for medical use. Two
of them, amantadine and rimantadine, are within the class of adamantane derivatives known to
bind and inhibit the influenza envelope proton channel M2. Amantadine was the first synthetic
substance shown to inhibit influenza virus replication (Davies et al., 1964). Despite their high
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effectiveness, the use of adamantan(amin)e derivatives is limited, mainly because several side
effects and broadly evolved resistance have been documented (Carlescu et al., 2009), especially
among H3N2 viruses (De Clercq, 2006).
The second class of influenza antiviral substances are neuraminidase inhibitors (von Itzstein,
2007). Influenza NA is critical for infection initiation (Ohuchi et al., 2006) as well as for the re-
lease of progeny viruses. Deletion of NA impairs infection and leads to virus aggregation on the
cell surface (Matrosovich et al., 2004b; Beigel and Bray, 2008). Two NA inhibitors, oseltamivir
(trade name Tamiflu) and zanamivir (trade name Relenza), are approved since 1999 and were
shown to be highly effective against influenza A and B viruses (Beigel and Bray, 2008). Both
compounds block the active sialic acid binding site of NA, of which the structure is known in-
cluding the position of resistance mediating mutations (von Itzstein, 2007).
A lot of experimental inhibitors targeting other viral proteins were discussed in the recent liter-
ature. The NP binding compound Nucleozin (Kao et al., 2010) and a new class of polymerase
inhibiting substances (Muratore et al., 2012) were effective against influenza virus replication in
vitro with negligible cytotoxicity. Another promising class of broad-spectrum antivirals based
on small chemical inhibitors was shown to inhibit a wide range of enveloped viruses by targeting
the virus membrane and interfering with membrane fusion (Wolf et al., 2010).
An additional approach that uses multiple SA residues on a multivalent scaffold as competitive
binding inhibitors is discussed in the section 1.3.2.
1.3 Multivalency
1.3.1 Mechanism of multivalent interactions
Multivalency describes the concept of multiple binding events happening at once and increasing
the overall binding strength. The simplest expression of multivalency is the simultaneous inter-
action of multiple receptor-ligand pairs. Multivalency is ubiquitous in biology and dramatically
enhances the overall avidity compared to the low single-interaction affinity. The term affinity is
used in this context to describe the attempt of a single receptor-ligand pair to form a complex. If
the interaction is mediated by many coexisting interactions the term avidity is often used (Mam-
men et al., 1998).
Its easy to imagine the effect of multivalency when thinking of a hook-and-loop fastener. One
single hook and loop pair is very weak, but an ensemble of many interactions can provide a
lot more resistance. Multivalency and positive cooperativity are not necessarily linked. The
best characterized example of positive cooperativity in biologic systems is hemoglobin. Here,
the second oxygen molecule binds to the tetrameric hemoglobin with higher affinity than the
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first, which results in positive cooperativity. In contrast, most multivalent systems are rather
negatively cooperative due to steric reasons.
K₁ =2 Kmono
K₁ = 4 Kmono
K₂=1/2 Kmono
K₂=1/2 Kmono
K= (Kmono)²
K= 2(Kmono)²
A
B C
Figure 1.6: Mechanism of multivalent interactions. Mechanism of multivalent binding depicted by
a bivalent example (A). Two monovalent ligands bind to two receptors and each ligand has the binding
constant Kmono, which gives 2 Kmono due to the presence of 2 receptors. The probability for the second
binding is reduced to 1/2 of Kmono. In contrast, if the two ligands are connected by a linker, the first
binding constant increases to 4 Kmono due to 4 possible binding situations. The second binding constant
strongly depends on the linker but is approximately equal to Kmono. The overall binding constant results
from the product of the two equilibrium constants K1 and K2. B and C illustrate two major mechanisms
that contribute to the multivalent effect. The local concentration after binding of the first ligand is strongly
increased, which leads to high re-association rates and higher functional affinity even in the case of only
one interaction. Multiple presented receptors allow many simultaneous interactions, which provides steric
stabilization of the complex (C). Adapted from (Fasting et al., 2012; Krishnamurthy et al., 2006)
Several mechanisms can influence multivalent binding. A high local concentration of lig-
ands promotes high re-association rates after dissociation and hence higher probability of bind-
ing for each individual ligand. In addition, the entropic penalty of the multivalent ligand to
escape the bound state is reduced. The overall entropy of a system with n receptors and n
free monovalent ligands depends on the solvation, rotation, and translation entropy (∆Smono =
∆Strans+∆Srot +∆Ssol). When a single ligand binds, the entire entropy will only slightly change.
In contrast, when the ligands are connected by a multivalent scaffold the system loses some of
its translation and rotation entropy if one individual ligand in the scaffold becomes connected to
a single receptor site. Hence, the first binding is entropically more difficult than the subsequent
binding events. As a direct consequence, the macroscopic dissociation is strongly reduced com-
pared to the monovalent ligand. The simplest case of a bivalent association is shown in Fig. 1.6
(e.g an antibody with two binding sites).
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1.3.2 Multivalency in biological systems
The binding between carbohydrates and carbohydrate-binding proteins (lectins) is typically very
weak. Since glycans are ubiquitous on biological surfaces, the majority of multivalent binding
systems are of the glycan-lectin type. Some of them are discussed below.
Host-pathogen interaction
Many enveloped viruses feature a dense layer of membrane spike proteins. These spike proteins
mediate the initial virus-cell attachment for influenza virus as well as other viruses like corona
viruses (e.g. severe acute respiratory syndrome (SARS) virus), rhabdoviruses (rabies virus,
vesicular stomatitis virus (VSV)) or simian virus 40 (SV40). The binding principle is similar
since all of them rely on multiple simultaneous interactions.
Bacteria are the second major pathogen group that interacts in a multivalent way with their
host cell. For example, cell adhesion of Escherichia coli and Helicobacter pylori depends on
multivalent glycan interactions (Lehmann et al., 2006; Mammen et al., 1998). Some bacteria
such as Vibrio cholerae or the recently discussed enterohemorragic E.coli (EHEC) secrete toxins,
which interact with cell-surface glycans in a multivalent way. Two of them, Cholera as well as
Shiga toxin belong to the pentameric AB5 class. Each monomer is composed of a cell binding
B subunit that delivers the cytotoxic A subunit (Collins and Paulson, 2004). Monomeric Shiga
toxin binding to its receptor has a dissociation constant in the mM range, while the multivalent
attachment to the cell has a Kd of 1 nM (Kitov et al., 2000). Recently, it was shown that binding
of Shiga and Cholera toxin as well as SV40 to GM1 gangliosides induces membrane curvature
an this presumably triggers endocytosis (Ewers et al., 2010). This is a direct link between
multivalent binding and downstream signaling caused by the provided scaffold (Ewers et al.,
2010).
Cell-cell interaction
The binding of leukocytes is a well characterized example of multivalent cell-cell interaction
(Ley et al., 2007). Leukocytes are very important during inflammatory processes. They circulate
in the blood until they recognize special lectins, so-called selectins, on the inner surface of the
vascular endothelium. L-selectins are present on leukocytes and P- and E-selectins are found
in the endothelium. All selectins bind sialyl LewisX (sLex) residues on the respective opposite
cell membrane. sLex is a complex carbohydrate that contains a terminal sialic acid as well as a
fucose branched from the subsequent lactose. This leads to binding and unbinding of leukocytes
to the vascular endothelium (leukocyte rolling) until they reach the cite of inflammation. Here,
additional integrin binding triggers extravasation of leukocytes into the inflamed tissue.
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Inhibition of influenza A virus activity using multivalency
The emergence of drug-resistant virus variants hinders the search for influenza antivirals. There-
fore it would be reasonable to assume that the globular head of HA due to its high variability, is
an unfavorable target for anti-influenza drugs.
However, many examples of multivalency in host-pathogen binding (some are discussed in 1.3.2)
inspired the idea of using this mechanism to interfere with cell adhesion. In the case of influenza
A virus, those inhibitors function as binding competitors that directly target the RBS of HA. As
mentioned before, the binding pocket is widely conserved to guarantee virus-host cell binding
(Skehel and Wiley, 2000).
Multivalent SA presentation has been done before, using the following approaches. Polymers
such as polyacrylamide (Sigal et al., 1996; Mammen et al., 1995), PAMAM (Reuter et al., 1999;
Landers et al., 2002) or the polysaccharide chitosan (Umemura et al., 2008; Li et al., 2011) bear
the advantage of good control of the molecule size. However, a disadvantage is that the degree
of functionalization (dF), i.e. the number of SA per molecule and the position on the polymers
is statistically distributed (statistical polymers). In other studies liposomes (Spevak et al., 1993),
proteins (Pritchett and Paulson, 1989) or only peptides (Zevgiti et al., 2011; Totani, 2003) were
successfully utilized to present multiple SA residues. The dF within the mentioned SA-carriers
covers a wide range between the simplest case of a bivalent peptide (Unverzagt et al., 1994) up
to several thousand SA residues on chitosan polymers (Umemura et al., 2008).
1.4 The biology of sialic acids
1.4.1 Glycosylation in mammalian cells
Sialic acid is a collective name for a group of 43 molecules, wherein the one that is N-acetylated
at the fifth position is called N-acetyl neuraminic acid, the primary sialic acid (Fig. 1.7 A). The
remaining nine carbon atoms within the conserved sialic acid backbone can be derivatized in
many ways forming this group of glycans (Varki and Schauer, 2009). Glycans can be attached
to proteins either by amide linkage (N-glycosilation) or glycosidic linkage (O-glycosylation).
This type of protein modification is achieved by about 200 glycosyltransferases in mammalian
cells (Moremen et al., 2012). The expression and competition of these proteins strongly in-
fluences the abundance and structure of different glycans in a certain cell or tissue (called gly-
come). The primary modification starts co-translationally in the ER by a protein complex, called
oligosaccharyltransferase (OST) (Fig. 1.7 D) (Lizak et al., 2011). OST, which is presumably
coupled to the Sec61 translocation protein, facilitates the transfer of an oligosaccharide from
a lipid bound precursor to the nascent polypeptide chain appearing from Sec61 (Kelleher and
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Gilmore, 2006). These early oligosaccharides mainly contain glucose (Glc), mannose (Man)
and N-acetyl glucoseamine (GlcNac) and are further processed by Golgi-localized enzymes,
which where shown to be spatially separated by the cis-trans morphology of the Golgi complex
(Rabouille et al., 1995). This hierarchical organizations and the fact that glycans can be either
extended or trimmed illustrates the variety of the resulting protein modification, as shown in a
mass spectrometry-based glycome analysis of CHO cells (North et al., 2010). ER-originated
glycans can be further extended with GlcNac, galactose (Gal) and terminal sialic acid. In addi-
tion, fucose residues can be attached to GlcNac at different positions, leading among others to
the earlier discussed sLex glycan. Notably, the terminal sialic acid can be attached to the adja-
cent Gal either by a -2,3 or 2,6-glycosodic linkage (Fig. 1.7 B, C), which is mainly determined
by the expression of Gal-specific sialyltransferases (Xu et al., 2011).
In addition to proteins, lipids can also be glycosylated. Glycosphingolipids are the major
group of glycolipids and contain the membrane bound ceramide, which is modified in the Golgi
apparatus in a hierarchical way, similar to proteins as described above. Glc and Gal are first
attached in the cis and medial Golgi apparatus. The glycan is further extended by attachment
of N-acetylgalactosamine (GalNac) and sialic acid. Sialylated glycosphingolipids are called
gangliosides, due to their discovery in brain samples. Gangliosides can be very complex and
contain multiple branches and SA moieties. As for proteins, ganglioside architecture mainly
depends on the tissue and the enzyme repertoire of the cell type.
1.4.2 Functions of sialic acids
Sialic acids are involved in many cellular recognition events and further function as a biologi-
cal mask in processes that were previously named as antirecognition (Schauer, 2009). A good
example of SA in antirecognition was already discussed in 1.3.2. The strong sialylation of red
blood cells prevents their aggregation due to the bulky electronegative surface and also sup-
ports the formation and opening of developing blood vessels (Strilic´ et al., 2010). Desialylation
of aged RBCs leads to recognition of open Galactose-endings by hepatocytes leading to their
clearance from the circulating blood (Kerfoot et al., 2008). On the other hand, oversialylation
protects malignant tumor cells or pathogens from being exposed to cellular defense mechanisms
(Schauer, 2009, 2000). The bacterium Streptococcus exposes SA and interacts with SA binding
proteins on neutrophils. This leads to decreased immune response and is also called molecular
mimicry (Carlin et al., 2009).
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Figure 1.7: Structure of sialic acid conjugates and synthesis of complex glycans in mammalian
cells. In mammalian cells, sialic acid is often modified (N-acetylated) at the fifth position (Neu5Ac).
The carbon atoms are numbered in red (A). Sialic acid is commonly coupled to galactose via a
α -2,3-(B) or -2,6 (C)-glycosidic linkage (shown in red). In D the glycosylation of transmembrane pro-
teins is briefly summarized. During the co-translational protein transport in the ER via the translocon
Sec61, oligosaccharyltransferases (OST) transfer oligosaccharides from lipid precursors to the nascent
peptide chain. These early oligosaccharides mainly contain glucose (Glc), mannose (Man) and N-acetyl
glucoseamine (GlcNac). The glycans are further modified by Golgi-localized glycosyltransferases, which
are localized at specific sites to ensure hierarchical glycosylation.
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Siglecs
Given the variety of SA derivatives and their terminal location, it seems obvious that SA is
used by numerous SA-binding proteins in various recognition mechanisms. Selectins on leuko-
cytes were already mentioned in 1.3.2. Another important group of proteins are SA-binding
immunoglobulin-superfamily lectins (Siglecs) (O Reilly and Paulson, 2009; Crocker et al., 2007;
Crocker, 2002). Siglecs are transmembrane proteins that belong to the immunoglobin superfam-
ily. They have several external immunoglobin repeats, in which the terminal carries the SA-
binding domain and a cytosolic tail where most Siglecs carry an immunoreceptor tyrosine-based
inhibitory motif (ITIM). ITIMs function as inhibitory receptors and suppress activation signals
that originate from receptors associated with immunoreceptor tyrosine-based activation motifs
(ITAMs) (Crocker et al., 2007). Siglecs are expressed on the surface of many immune cells and
specifically recognize SA and the linkage to Gal. These proteins mediate interactions in cis- as
well as trans (i.e. on the same cell or between cells) (Crocker et al., 2007; Crocker, 2002). Many
Siglecs are masked by cis-mediated SA binding due to a very high local SA concentration on
immune cells.
SA in host-pathogen interactions
Haemophilus in uenzae, a bacteria that is found at high abundance in the lungs of flu patients
and thus was regarded as the causative agent until the influenza virus was discovered in 1933
(Taubenberger et al., 2007), was found to posses SA-specific lectins (Lehmann et al., 2006).
Today, it is known that influenza is caused by an influenza virus infection and that flu patients
often suffer from secondary bacterial infections (superinfection), which presumably caused most
of the fatal casualties of the 1918 flu pandemic (Taubenberger et al., 2007). As mentioned in
section 1.3.2, some bacteria such as Clostridium botulinum and Vibrio cholerae secrete solu-
ble toxic lectins. These toxins bind gangliosides and subsequently enter cells by endocytosis
where in the cytoplasm they exhibit catalytical activity on cellular proteins. Another group of
SA-binding pathogens are protozoic parasites. Plasmodium falciparum the causative pathogen
of Malaria was shown to use SA for erythrocyte binding (Varki and Varki, 2007). In addition,
various strains of Leishmania as well as Trypanosoma utilize SA as a host-cell interaction part-
ner (Lehmann et al., 2006). Some pathogens have also evolved to use SA in combination with
host-cell specific lectins for cell-adhesion. For Porcine Reproductive and Respiratory Syndrome
virus (PRRSV) it was shown that the Siglec sialoadhesin in combination with heparan sulfate
are necessary for virus attachment and uptake into pig alveolar macrophages (Delputte et al.,
2005). Neisseria meningitidis, the causative agent of meningitis, utilizes sialoadhesin as well as
Siglec-5 for attachment to macrophages.
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In conclusion, the diversity and the exposed position of SA on mammalian glycans have pre-
sumably co-evolved with a great variety of pathogens that use SA as specific attachment sites.
SA-synthesizing as well as SA-deficient organisms (such as plants) have developed SA-binding
lectins to recognize SA residues with great specificity (Lehmann et al., 2006). Other examples
for SA-mediated host-pathogen interactions are summarized in Table 1.2.
Table 1.2: Sialic acid mediated host-pathogen interaction. VP, virus protein; HN, hemagglutinin neu-
raminidase; EBA, erythrocyte-binding antigen; PRRSV, porcine reproductive and respiratory syndrome
virus; sd, strain dependent; TS, trans sialidase
pathogen pathogen host
name factor factor
Viruses Influenza A virus HA SA
Simian Virus 40 VP1 GM1
Rotavirus VP4 GM1
Newcastle desease virus HN GM1-3
PRRSV SA Sialoadhesin
Bacteria Escherichia coli sd SA
Streptococcus sd SA
Helicobacter SabA SA
Haemophilus in uenzae HifA SA
Vibrio cholerae cholera toxin SA
Clostridium botulinum botulinum toxin SA
Neisseria meningitidis SA Sialoadhesin,
Siglec-5
Protozoic
parasites
Plasmodium falciparum EBA SA
Trypanosoma cruzi inactive TS SA
Leishmania nd SA
1.5 Single molecule manipulation
Regarding the number of molecules that are present within a given system, there are at least
two investigational approaches. The first and classical one is the ensemble or bulk approach,
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where a large number of molecules in a certain reaction/experimental condition are followed.
This approach is very robust, but the result is an average of a population of molecules. But
probably, each molecule behaves differently and the average does not account for the biologic
variability. A similar situation is valid for single cells within a population. Here the term cell-
to-cell variability was introduced and investigated in several experimental approaches, with the
result that cells in a population strongly differ in their response to a certain external cue (e.g
endocytosis) (Snijder and Pelkmans, 2011; Snijder et al., 2009).
To look on processes or cells in singulo can reveal details about the mechanisms and real kinetics
of a reaction. While single-cell methods (e.g. high resolution microscopy) provide information
about the behavior of single cells, for the manipulation and description of single molecules, other
methods are necessary. Two of these methods, optical tweezers and atomic force microscopy,
will be described in the next section.
1.5.1 Optical tweezers (OT)
Optical tweezers originate from an observation made by Arthur Ashkin in 1970 (Ashkin, 1970).
Ashkin observed, that the momentum transported by light can exert forces on particles with
different refractive index compared to the surrounding medium. The forces that determine an
optical trap are sketched in Fig. 1.8. Importantly, optical traps use high-power lasers with a
gaussian beam profile, i.e. the center beam has the highest intensity. To minimize interaction
with biological specimen by the high-power lasers (3W), the lasers operate with near-infrared
light with a wavelength of 1064 nm (Wozniak et al., 2009). In comparison, conventional confocal
microscopes use lasers at 10-20 mW.
If this laser light hits a spherical particle (e.g. a bead, Fig.1.8) the light is refracted at the edges of
the bead, changing the direction of the deflected beam (Veigel and Schmidt, 2011). This causes
a momentum change of the light beam and induces a momentum transfer onto the bead. The
amount of the momentum transferred onto the bead depends on the intensity of the deflected
light and thus on the gaussian beam profile. Hence, the total force exerted on the particle is
combined of forces produced by the different rays within the beam. This is called the gradient
force and represents the most important force component of optical traps.
The second component is also based on the particle characteristic of the light, which can induce
radiation pressure. The so called scattering force pushes the particle in the direction of the
propagating beam. The gradient force must overcome the scattering force, which is realized
experimentally by using a high-numerical aperture (NA) objective and creating a steep light
intensity gradient (Neuman and Nagy, 2008). As a result of both components, the particle is
stabilized in the center of the beam slightly downstream of the focus (Veigel and Schmidt, 2011).
The x-y position of the trapped particles can be measured by detecting the laser beam with nm-
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precision on a quadrant photodiode (QPD), a light-sensitive diode that is divided into four equal
segments. The total light intensity reaching the detector provides informations about the particle
position in z-direction. After calibrating the optical trap, displacement of a particle from the
center of the beam can be directly translated into the applied force. This allows to investigate
processes at the level of single molecules.
Figure 1.8: Mechanism of optical trapping. Optical tweezers operate with high power near-infrared
lasers with a gaussian beam profile (i.e. the center beam has the highest intensity), which are focussed by
a high NA microscopic objective (A, lower panel). In case of a spherical particle getting into proximity of
the beam focus, the beam will be deflected at the edges of the particle, which leads to a changed direction
of the deflected beam (A, upper part). This causes a momentum change of the light beam and a resulting
momentum transfer on the bead directed in the opposite direction (B). The total force applied on the
particle (green arrow) is the sum of forces produced by the different rays within the beam (C).
1.5.2 Atomic force microscopy (AFM)
In contrast to optical tweezers, the atomic force microscope is a contact tool, where a sample is
probed by a mechanical sensor (scanning probe microscopy (SPM)). The sensor is a very sharp
tip at the end of a cantilever arm. The tip is of pyramidal shape, with a tip diameter of only a
few nm. The AFM tip scans surfaces and creates a contour image of the sample. The position
of the tip is measured by pointing a laser beam at the cantilever and detecting the reflection with
a photodiode. If the tip scans an uneven surface the cantilever will bend and alter the signal
produced at the photodoide (Fig. 1.9A). In combination with rasterized sample scanning, the
topography of a biological specimen can be determined. AFM can reach spatial resolutions of
1nm, which allows imaging of single proteins such as rhodopsin (Fotiadis et al., 2003) or
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connexin 26 gap junctions (Müller et al., 2002).
The precise detection of the cantilever position enables force measurements in axial direction.
The cantilever can be functionalized using highly specific and resistant attachment methods
(Ebner et al., 2009) with proteins, cells or viruses (Muller, 2008). In force spectroscopy mode,
the functionalized cantilever is lowered on a interacting surface (e.g. a cell) until binding occurs
or the cantilever touches the surface. The cantilever is retracted and in case of a binding event
will bend until the underlying bond fails and the cantilever returns into the zero-force position.
The process is called a force-distance cycle and permits atomic force spectroscopy experiments
as well as OT-based force spectroscopy (Fig. 1.9B).
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Figure 1.9: Components of an atomic force microscope and illustration of a force distance cycle.
Components and the principle of atomic force microscopy (A).The sample is attached to a piezoelectric
scanner that allows movement with nm-precision. The sample is scanned with a very sharp tip (tip
diameter 5-10 nm) attached to a cantilever. The cantilever acts as a Hookean spring and hence bending
can be translated into applied force. The deflection of the cantilever is measured by pointing a laser on
the back of the cantilever and detecting the reflection on a quadrant photo diode (QPD). During a force-
distance cycle (B) the cantilever is lowered until touching the surface of the sample (1). Subsequently,
the cantilever is retracted at a defined velocity. In case of an interaction, the cantilever will bend towards
the sample (2) until the underlying bond fails and the cantilever returns into the zero-force position (3).
1.6 Single molecule force spectroscopy (SMFS)
A variety of experimental studies at single-molecule level illustrates the versatility of AFM
and OT. Well-known examples for OT-based experiments are investigations of walking motor
proteins such as myosin and kinesin or of the catalytic activity of DNA-binding enzymes (Fazal
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and Block, 2011). The two first studies that describe the mechanical unfolding of a single protein
were conducted in parallel by AFM and OT and were published together in 1997 (Rief et al.,
1997; Kellermayer et al., 1997). Thereafter, AFM was successfully used to study the unfolding
of rhodopsin (Oesterhelt et al., 2000) and the unbinding of biotin from streptavidin (Yuan et al.,
2000). However, except for the study of Yuan and colleagues (Yuan et al., 2000), these studies
describe processes that where monitored by spatial displacement. In dynamic force spectroscopy
(DFS), the resistance of a discrete molecular interaction is probed under tension in a dynamic
range of force loads. This includes a repetitive scheme of force distance cycles (Fig. 1.9 B) while
varying the pulling velocity (i.e. force load or loading rate) (Hinterdorfer and Dufrêne, 2006).
In force spectroscopy, the AFM cantilever and the optical trap, respectively, act as a Hookean
spring, which is connected to the interacting sample. When the spring constant of the cantilever
(or the stiffness of the optical trap) is known, the deflection linearly scales with the applied force.
During a pulling experiment, the anchor between sample and bead or cantilever must be more
resistant than the interaction to be investigated. In this case, the investigated interaction will
unbind first and the resulting rupture force (F) in most cases increases with the applied loading
rate (r) (Müller et al., 2009). A model to describe this relation was introduced by Bell and Evans
(Eq. 1.1) (Evans, 1999; Evans and Ritchie, 1997; Bell, 1978). According to the model, the most
probable rupture force (F) increases with increasing loading rate (r) (Fig. 1.10), which can be
controlled by the pulling velocity v leaving the force the only unknown parameter. Looking at
the energy landscape of a simple ligand-receptor interaction, the bound state is separated from
the unbound state by an energy barrier (Fig. 1.10). The height of the barrier determines the
spontaneous unbinding rate (koff) and its position is at xu along the reaction coordinate (Rief and
Grubmüller, 2002).
F(r) =
kBT
xu
ln
(
rxu
ko f f kBT
)
(1.1)
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Figure 1.10: Bell-Evans model of single molecule force spectroscopy. The model describes the tran-
sition of a receptor-ligand interaction between a bound and an unbound state (A). The energy landscape
of this interaction is shown in black. The interaction must overcome a single energy barrier with the
height ∆G. In case a pulling potential is attached to one of the binding partners, the energy barrier is
lowered and this allows unbinding. According to the model, the most probable rupture force F increases
exponentially with increasing loading rate r (B). That means that the failure rate of the bond increases
and the lifetime decreases. In the case depicted in A, a single energy barrier is overcome which leads to
a linear dependence of F against logr (C). The curve can be described using Eq. 1.1 and provides the
dissociation rate without force koff and the position of the transition state xu.
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1.7 Aims of this thesis
Influenza poses a constant threat to public health and is under continuing surveillance by several
institutions worldwide. In order to develop new antiviral strategies, it is highly important to un-
derstand the details of virus replication. In the course of its complex infectious cycle, influenza
A virus must deliver its genome to a host cell and hijack the cells reproductive machinery to
eventually initiate its own replication. Recent studies indicate that essential parts of the replica-
tive cycle, including the early phase of binding and invasion are still not well understood. For
example, virus-cell binding might not solely depend on different conformations of sialic acid.
Rather, attachment is a heterogeneous process that is affected by the virus presenting its spike
protein HA as well as the cell presenting the corresponding receptors. Another example, as we
reasoned, is an optimized interplay between endosome acidification and structural intermediates
of viral components eventually leading to release of the virus genome into the host cell. This
close correlation goes far beyond the low pH-triggered conformational change of HA as the only
driving force behind genome release.
This thesis provides a detailed study about the initial phase of influenza virus infection. Virus
binding was investigated using an experimental system that closely mimics the natural situation.
Via modern OT- and AFM-based force spectroscopy, virus binding was studied at the single
molecule level. Using this approach combined with the characterization of cell surface gly-
cans gives an unprecedented insight into receptor binding specificity. The subsequent infection
steps were investigated by high-resolution fluorescence microscopy. Virus labeling and parallel
expression of cellular markers allows studying the trafficking and fusion kinetics of individual
viruses. Further, pH-sensitive fluorophores were utilized to trace endosomal acidification kinet-
ics at single vesicle- and whole cell level.
Considering known problems and drawbacks of current anti-influenza therapy (e.g. development
of resistances), we demonstrate exemplarily that results from the present study can be used to
develop target-directed antiviral drugs. We used our results to design and evaluate competitive
binding inhibitors - a potential new class of influenza antivirals. Receptor-coated nanoparticles,
which mimic the cell surface, provide a high affinity alternative for the virus to bind. Particle-
based inhibitors were tested using assays to study HA-related virus activity, including virus-cell
binding and fusion.
In summary, this comprehensive investigation of the first steps of influenza virus infection iden-
tifies potential targets for antiviral therapy. The study further gives an example how the detailed
analysis of virus binding can directly be translated into effective antiviral approaches.
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2.1 Materials
2.1.1 Biological Material
Cell lines
Name Species Origin Source
MDCK 2 Canis familliaris kidney epithel ATCC: CCL-34
CHO K1 Cricetulus griseus ovary, epithel like ATCC: CCL-61
A549 Homo sapiens epithel ATCC: CCL-185
Virus strains
Influenza A/X-31 (H3N2) was grown in 10-day old embryonated chicken eggs as described
in 2.2.3. X-31 is a reassortant influenza strain between A/Aichi/2/68 (H3N2) and A/Puerto
Rico/8/34 (H1N1). HA and NA define the antigenic phenotype. X-31 carries HA and NA
from influenza A/Aichi/2/68 and is thus considered a H3N2 virus. Influenza A/WSN/33 and
A/Panama/99 were grown in MDCK cells and concentrated from cell supernatant by ultracen-
trifugation at 100.000 g for 1.5 h. The purity of the virus samples was verified by SDS-Page.
Plasmids
Name Insert Source
pEYFP full HA-YFP kindly provided by M. Veit (FU Berlin)
pCDNA3 Rab5-GFP kindly provided by V. Haucke (FU Berlin)
pEGFP Rab7-GFP kindly provided by V. Haucke (FU Berlin)
27
2 Materials and Methods
2.1.2 Media and Solutions
Cell Culture Media and reagents
Application Composition Source
Cell growth DMEM
10 % fetal calf serum
200 mM L-glutamine
1 % Penicillin/Streptomycin
PAA
PAA
PAA
PAA
Cell passaging PBS with/without
100 mg/ml CaCl and MgCl
PBS with 0.5 mg/ml Trypsin,
0.22 mg/ml EDTA
PAA
PAA
Cell freezing
medium
70 % DMEM
20 % fetal calf serum
10 % DMSO
Infection
medium
DMEM
0.2 % BSA
PAA
Sigma
Transfection Lipofectamine2000
Turbofect
Invitrogen
Fermentas
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Buffers
Buffer Composition
PBS 137 mM NaCl, 2.7 mM KCl,
10 mM Na2HPO4 + 2 H2O, 1.76 mM KH2PO4
Fusion buffer 150 mM NaCl,
10 mM Sodium acetate, pH 7.4
Cell fusion buffer 10 mM HEPES, 10 mM MES
150 mM NaCl, pH 5
Stacking SDS-gel buffer 1 M Tris/HCl pH 6.8
Separating SDS-gel buffer 1 M Tris/HCl pH 9.0
SDS loading buffer 63 mM Tris/HCl, 10 % glycerol,
2 % SDS, 0.0025 % Bromophenol blue
100 mM -mercaptoethanol
SDS running buffer 25 mM Tris/HCl, 192 mM glycine, 0.1 % SDS
Fixation buffer PBS, 2 % Paraformaldehyde
0.02 % Glutaraldehyde
Permeabilization buffer PBS, 0.2 % BSA, 0.2 % Triton X-100
Antibody diluent PBS, 0.2 % BSA
Fixation buffer (FACS) PBS, 2 % Paraformaldehyde
Permeabilization buffer (FACS) PBS, 0.2 % Saponin
Blocking buffer (FACS) PBS, 0.2 % Saponin, 2% BSA
Antibody diluent (FACS) PBS, 0.2 % Saponin, 2% BSA
standard pH buffer
pH 4.5 - 7.5
mixing 50 mM HEPES with 50 mMMES both con-
taining 50 mM NaCl
30 mM ammonium acetate, 40 mM sodium azide
10 μM Monensin or Nigericin
hemolysis buffer 10 mM Na2HPO4 + 2 H2O, 1.76 mM KH2PO4
pH 7.4
2.1.3 Reagents
Chemicals
Standard chemicals were obtained from Merck, Sigma and Roth. Others are listed below.
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Name Source
Nocodazole Sigma
Cytochalasin D Sigma
Ammonium chloride (NH4Cl) Sigma
Bafilomycin A Sigma
Monensin Sigma
Nigerizin Sigma
Amantadine Sigma
Neuraminidase from Clostridium perfringens Sigma
PageRuler ™ Prestained Protein Ladder Fermentas
Mowiol Roth
Octylglycoside Boehringer
Fluorescent Markers
Name Source
octadecylrhodamine B (R18) Invitrogen
1,1 -dioctadecyl-3,3,3 ,3 - tetramethylindodicarbocyanine (DiD) Invitrogen
4-(4-(Dihexadecylamino)styryl)-N-Methylpyridinium Iodide
(DiA)
Invitrogen
1,1 -dioctadecyl-3,3,3 ,3 -tetramethylindocarbocyanine perchlo-
rate (DiI)
Invitrogen
4,4 -Bis (1-anilinonaphthalene 8-sulfonate), bis-ANS Invitrogen
4 ,6-diamidino-2-phenylindole, DAPI Invitrogen
Hoechst 33342 Invitrogen
Rho-Phalloidin Invitrogen
Lysotracker™ Red Invitrogen
FITC-dextran (10.000 kDa) Sigma
FITC/Rhodamine-dextran (10.000 kDa) Invitogen
Propidium iodide Sigma
Lectin from Triticum vulgaris, WGA (FITC conjugate) Sigma
Lectin from Maachia amurensis, MAA (Rhodamine conjugate) EY Laboratories
Lectin from Sambucus nigra, SNA (FITC conjugate) EY Laboratories
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Antibodies
Primary antibodies
Antigen Species Source
Influenza A nucleoprotein mouse Millipore
Influenza A nucleoprotein,
FITC conjugate
mouse Millipore
Influenza A H3N2 polyclonal goat Virostat
Influenza A H3N2 M1 goat Virostat
-tubulin mouse Sigma
Secondary antibodies
Conjugate Source
anti-mouse IgG Cy2 Amersham
anti-mouse IgG Alexa 568 Invitrogen
anti-goat IgG Cy3 Sigma
2.1.4 Kits
Name Source
BCA Protein Assay Reagent Kit Pierce
Total Protein Kit Lowry Sigma
QIAprep Spin MiniPrep Kit Qiagen
Plasmid MaxiPrep Kit Qiagen
RNEasy Mini Kit (RNA Isolation) Qiagen
Celltiter Blue Cell Viability Assay Promega
2.1.5 Multivalent polyglycerol and gold nanopraticles
All multivalent polyglycerol particles (PG) were synthesized and provided by Dr. Ilona Papp
and Prof. Dr. Rainer Haag (FU Berlin). Gold colloids (AuNP) were synthesized by Dr. Meike
Roskamp and Prof. Dr. Sabine Schlecht (now Justus-Liebig-Universität Gießen). Final func-
tionalization of gold colloids was performed by Dr. Ilona Papp. The particles vary in their size
and degree of functionalization (dF).
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Name MW (kDa) diameter (nm) Df (%) SA units
PG 1 6.6 3 0.1 15 6
PG 2 14.4 3 0.7 50 20
PG 3 23 3 1.3 90 35
sulfated PG 6.5 4 1.1 85 0
PG 4 8,000 50 5.6 12 10,000
PG 5 27,000 70 6.8 80 60,000
SA AuNP n.d. 14 full 10.000
SA AuNP n.d. 2 full 2.000
OH AuNP n.d. 14 full only OH
2.1.6 Consumables
Material Source
Cell culture flasks (T25, T75, T175) Nunc
Cell culture plates Nunc, Sarstedt
96-well, μclear cell culture plate, black Greiner
cell scraper Sarstedt
Cryo tubes (1.5 ml) Sarstedt
Round bottom tubes, 5 ml Sarstedt
Glass bottom petri dishes, 35 mm MatTek
Microscopy glass slides Roth
Glass cover slips Roth
Fluorescence cuvette, 10x10 mm Hellma
Parafilm® Pechiney
Slide-A-Lyzer dialysis casette Pierce
Polystyrene beads
1.5 μm
Bangs Laboratories
2.1.7 Equipment
Experiments were done using standard modern laboratory equipment. Others are listed below.
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Name Configuration
Olympus FV-1000 IX-81 microscope
60x/1.2 Water UPlanSApo
405, 560 nm diode lasers
458, 488, 515 nm Argon laser
3 confocal PMTs
climatization chamber
Olympus FV-1000MPE IX-81 microscope
60x/1.2 Water UPlanSApo
405, 440, 560, 635 nm diode lasers
(458), 488, 515 nm Argon laser
3 confocal PMTs
climatization chamber
Olympus IX-81
epifluorescence microscope
HBO lamb
60x/1.35 Oil Zeiss
Filter cubes: U-MWNiba, U-MWG2
BD FACScan 488 nm argon laser line
Filters: 560 SP, 530 SP
BD FACSAria II 375, 488, 405, 633 nm laser line
Filters: 515 - 545 nm, 564 - 606 nm,
600 - 620 nm
Horiba Jobin Yvon Fluoromax 4
steady state fluorescence spectrometer
high-power xenon light source
temperature-controlled sample cham-
ber with stirrer
Eppendorf
Biophotometer Plus
equipped with a microliter
sample cell (IMPLEN)
CASY ® cell counter
Model TTC 45/60/150
150 µm capilary
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2.1.8 Software
Name Supplier
Olympus FV1000 3.1 Olympus
MetaMorph Molecular Devices
CellQuest Beckton Dickinson
FACS Diva Software Beckton Dickinson
FlowJo Tree Star, Inc.
ImageJ US National Institute of Health (NIH)
Localize for IDL kindly provided by Daniel R. Larson (NIH, USA)
Photoshop Adobe®
Illustrator Adobe®
Matlab The Mathworks
Igor Pro Wavemetrics
FluorEssence™ Horiba
Origin OriginLab
PyMOL DeLano Scientific LLC
Microsoft Office 2003 Microsoft
Prism GraphPad Software, Inc.
LATEX
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2.2.1 Cell culture
The cells were propagated in growth medium in 25, 75 or 175 cm2 culture flasks at 37 C and
5% CO2. The cells were passaged every 3 - 5 days before they had reached full confluency. To
this end, the cells were washed twice with PBS -/- and detached using trypsin-EDTA at 37 C
for 5 - 15 min. Trypsinization was stopped by addition of growth medium and approximately 1
106 cells were seeded in a new 75 cm2 culture flask. For the different assays, cells were seeded
into 6-, 12-well plates or petri dishes. For long term storage, the cells from one 75 cm2 culture
flask were detached, pelleted for 5 min at 2000 g and resuspended in freezing medium. The cells
were kept at -80 C for 24 hours and subsequently stored in liquid nitrogen.
2.2.2 Cell viability assay
To monitor the cell viability under the used experimental conditions, two assays were used. The
Celltiter Blue Cell Viability Assay uses the metabolic conversion of resazurin to resorufin by
metabolically active cells. This results in a fluorescent product which can be measured at ex =
560 nm / em = 590 nm. Cells were grown in a μclear 96-well plate, washed once with PBS and
incubated with 25 μl of the indicated test substance at 37 C. The volume was added up to 100
μl with DMEM and 25 μl Celltiter blue reagent was added. The cells were incubated for 1h at
37 C. The fluorescent signal was recorded on a Tecan 200 Pro microplate reader. As a flow
cytometric alternative cells where detached from the cell culture plate using PBS -/- containing
2 mM EDTA. The cells were washed in PBS, peletted (2000 g, 5 min) and resuspended in
PBS. Propidium iodide (PI) was added to a final concentration of 1 μg/ml, briefly vortexed
and immediately analyzed by flow cytometry. PI is membrane impermeable and excluded from
viable cells which show a much lower fluorescence signal.
2.2.3 Virus preparation
Influenza A virus X-31 (H3N2) was propagated in chicken eggs as follows. Embryonated
chicken eggs were cultured in a home-made incubation chamber that allows constant tempera-
ture of 37 C and rotation of the eggs. After 11 days, allantoic fluid from a previous preparation
(09.11.97) was diluted 1 : 500.000 and 200 μl were injected into the allantoic cavity of each egg.
The virus was allowed to propagate within the cells of the allantoic cavity for 48 h before the
allantoic fluid was collected. The fluid was cleared from cell debris by low speed centrifugation
at 3000 g for 30 min. The virus was pelleted by ultracentrifugation at 100.000 g for 90 min. The
virus pellet was resuspended in PBS and homogenized with a Teflon-coated homogenizer. At
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last the total protein content was determined by BCA assay and the virus was stored in aliquots
at -80 C.
2.2.4 Preparation of red blood cell ghosts.
Purified human erythrocytes (Blutbank, Charité) were washed three times in PBS (2000 g, 10
min). One volume of erythrocytes (red blood cells, RBC) was resuspended in 10 times the
volume ice cold hemolysis buffer. The cells were lysed for 30 - 50 min on ice and centrifuged
for 20 min at 5000 g. The lysed RBCs were incubated on ice for 10 min with occasional stirring.
This lysis-washing cycles were repeated until the pellet appeared white. The cells were washed
in PBS, pelleted and stored at 4 C with 0.02 % sodium azide.
2.2.5 Whole cell-virus binding assay
Influenza A virus was labeled with octadecylrhodamine B (R18) as follows. The virus was
diluted to a concentration of 1 mg/ml in PBS and incubated with R18 (20 μM final conc.) for
30 min at RT. Unbound R18 was removed by centrifugation for 5 min at 50.000 g. The pellet
was resuspended in PBS. Red blood cells were washed in PBS and diluted to 1%. 40 μl RBCs
( 108 cells) were mixed with 10 μl labeled virus and incubated at RT for 20 min. Unbound
virus was removed by centrifugation (5 min, 1200 g). The pellet was resuspended in PBS,
and the fluorescence per red blood cell was measured by flow cytometry on a BD FACScan
and FACSAria II flow cytometer. The data were acquired using BD CellQuest and FACSDiva
software. The data were analyzed using FlowJo. Virus binding to adherent cells was analyzed
as follows. Cells were detached from the culture plate using PBS -/- supplemented with 2 mM
EDTA for 20 - 40 min at 37 C. The cells were washed in PBS, the cell number was determined
using a Casy cell counter and 2 105 cells were mixed with 10 μg labeled virus for 20 min at
RT. Unbound virus was removed by centrifugation (5 min, 1200 g) and the sample was analyzed
as described above.
2.2.6 Hemagglutination inhibition assay (HAI)
Influenza viruses bind to and crosslink erythrocytes due to their spike protein HA. This process
is called hemagglutination and serves as a method to determine the amount of virus in a given
sample. However, it can also be used to evaluate binding inhibitors. First, the minimal effective
virus concentration (HA Titer) was determined. Influenza A/X-31 virus was diluted to 1 mg/ml
protein concentration in PBS. In a 96-well plate 25 μl virus were serially diluted in an equal
amount of PBS -/-. Purified human RBCs were washed with PBS and diluted to 1%. 50 μl RBCs
were added to the virus dilution and incubated for 1 h at RT. Effective hemagglutination resulted
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in a gel when viewed from the top. If the virus concentration was too low the RBCs settle and
formed a pellet on the bottom of the well (Fig. 2.1). The minimal effective virus concentration
was tripled and incubated with serially diluted inhibitors for 30 min at RT until RBCs were added
as described above. The lowest concentration that still prevents hemagglutination is defined as
the KHAI.
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Figure 2.1: Hemagglutination inhibition assay (HAI). Influenza viruses are able to agglutinate red
blood cells. The assay is performed in a 96-well plate format. Viruses are mixed with human erythro-
cytes which are eventually cross-linked and form a gel seen from above. This effect can be used to
determine virus titers or the effect of potential competitive binding inhibitors. In this case the virus is
pre-incubated with an inhibitor, which can inhibit RBC binding. The inhibitor is serially diluted and the
lowest concentration that still prevents hemagglutination is defined as the KHAI
2.2.7 Influenza virus fusion assay
Virus-cell fusion was measured by monitoring the fluorescence de-quenching (FDQ) of the lipid-
like fluorophore R18 upon fusion of R18-labeled viruses with ghost membranes (Krumbiegel
et al., 1994). To this end, 10 µl labeled virus suspension (1 mg/ml) was mixed with 40 µl ghost
suspension (≈ 2∗ 105 cells) and incubated for 20 min at RT. Unbound virus was removed by
centrifugation (5 min, 1200 g). The virus-ghost suspension was transferred to a glass cuvette
containing pre-warmed fusion buffer (pH 7.4), and the fluorescence was detected (λ ex = 560
nm; λ em = 590 nm) by using a Horiba Yobin Yvon FluoroMax spectrofluorometer. Fusion was
triggered by the addition of citric acid (0.2 M). The suspension was stirred continuously with a
2 by 8 mm Teflon-coated magnetic stirring bar. After 600 s the fusion was stopped by adding
Triton X-100 (50 µl, final concentration 0.5%) to obtain maximum R18 de-quenching. The
final pH in the cuvette was measured using a standard pH meter. The percentage of FDQ was
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calculated as:
FDQ(%) =
F(t) F(0)
(Fmax F(0))
100 (2.1)
where F(0) and F(t) are the fluorescence intensity before starting fusion and at a given time
(t), respectively.
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Figure 2.2: Influenza virus-cell fusion assay. Influenza virus was labeled with R18 at self-quenched
concentration. The labeled virus was incubated with red blood cell ghosts for 20 min at RT. Unbound
virus was removed by centrifugation (5 min, 1200 g). The virus-ghost suspension was transferred to a
glass cuvette containing pre-warmed fusion buffer (pH 7.4), and the fluorescence was detected ( ex = 560
nm; em = 590 nm) by using a Horiba Yobin Yvon FluoroMax spectrofluorometer. Fusion was triggered
by setting the pH to 5 by adding citric acid (0.25 μM). The fusion was stopped by adding Triton X-100
(50 μl, final conc. 0.5%) to obtain maximum R18 de-quenching.
2.2.8 Infection with influenza virus
Approximately 1-5 106 MDCK cells were seeded 14 - 24 h prior to the experiment in 35 mm
petri dishes or on 15 mm glass cover slips in a 12-well plate. Influenza A virus was diluted in
PBS to a final protein concentration of 1 mg/ml. The virus was then further diluted in infection
medium to a final concentration of 20 μg/ml, which corresponds to a MOI of 25 - 50. The virus
was added to adherent cells and after 1 h of adhesion at 37 C, unbound virus was removed, and
the cells were incubated in infection medium for 5 - 7 h.
2.2.9 Live cell microscopy
All microscopic experiments using living cells were performed in 35 mm petri dishes. The used
microscope was equipped with an incubation chamber that provided constant temperature of 37
C as well as 5 % CO2.
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2.2.10 Immunostaining for microscopy and flow cytometry
For microscopy, the cells were washed twice in PBS and fixed for 30 min in fixation buffer. The
cells were washed again twice in PBS and transferred into permeabilization buffer for 20 - 25
min. Primary antibodies were diluted 1:1000 and either dropped in the middle of a glass bottom
petri dish or 20 μl were dropped on Parafilm and cells growing on glass slides were put upside-
down on the drop. The cells were labeled for 1 h at RT, washed in PBS 3 10 min and incubated
with the secondary antibody for 1 h. The cells were counterstained with DAPI in PBS at a final
concentration of 0.2 μg/ml and finally washed 3 10 min. Cells in petri dishes were directly
used for microscopy in PBS buffer. Glass cover slips were mounted on glass slides using mowiol
and after drying were stored in the dark at 4 C. For flow cytometry, the cells were scraped from
the petri dish and fixed for 20 min fixation buffer. The cells were kept on ice throughout the
staining. The cells were washed, pelleted at 1000 g for 5 min and permeabilized for 20 min. The
cells were incubated in blocking buffer for 20 min and labeled with the first antibody for 45 min.
The cells were washed 3 5 min and labeled with the secondary antibody for 30 min. After a
final washing step the cells were kept on ice until analysis. Fluorescence values per cell were
measured by using a Beckton Dickinson FACScan or FACSAria II flow cytometer and data were
acquired using BD CellQuest and FACSDiva software. The data were analyzed using FlowJo.
2.2.11 Transfection of expression plasmids
Cells were transfected with expression plasmids using Lipofectamine2000 or Turbofect accord-
ing to the manufacturers manual. To this end, cells were seeded in 35 mm glass bottom petri
dished and grown until they reached 70 - 90 % confluency. 10 μl Lipofectamine2000 and 4 μg
DNA were diluted separately in 250 μl serum-free medium. After 5 min DNA and Lipofec-
tamine2000 were mixed and further incubated for 20 min at room temperature. The cells were
washed in PBS and the DNA/Lipofectamine2000 mix was added with additional 1.5 ml serum-
free medium. After 4 h the medium was changed to growth medium. The protocol is essentially
the same for Turbofect, but without medium change after 4 hours.
2.2.12 Intracellular pH measurement
To determine the pH inside individual endosomes, one has to introduce a pH sensitive molecule
into the endocytic pathway. To this end, endocytic uptake markers labeled with pH (in)sensitive
fluorophores were used. MDCK cells were seeded in glass-bottom petri dishes one day prior to
the experiment. On the day of the experiment, the cells were serum-starved in DMEM for 30
min at 37 C. FITC/Rhodamine conjugated dextran was added at a concentration of 10 mg/ml
in DMEM. The cells were incubated for 5 min at 37 C (Pulse), washed 3 times with PBS,
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transferred into pre-warmed DMEM and the fluorescence was immediately followed using a
confocal microscope (Chase). For flow cytometric pH determination, the cells were detached
from the petri dish after the serum-starvation using PBS -/- supplemented with 2 mM EDTA.
The cells were washed 3 times in PBS (centrifugation at 2000 g, 5 min) and incubated in 10
mg/ml FITC/Rho-Dextran for 5 min at 37 C in a pre-heated water bath. The cells were pelleted,
divided into aliquots of 105 cells and chased for up to 60 min. Each aliquot was diluted in PBS
and the fluorescence was immediately quantified by flow cytometry.
In order to measure the pH inside individual endosomes in the presence of a virus particle, the
virus was diluted to 1 mg/ml and labeled with 20 μM DiD for 2 h at RT. To remove unbound
dye, the virus was centrifuged at 50.000 g for 10 min, resuspended in PBS and diluted in 10
mg/ml FITC-Dextran. The suspension was added to the cells and internalized for 5 min at
37 C. The cells were washed in PBS, transferred in pre-warmed DMEM and the fluorescence
was immediately followed using a confocal microscope. In the microscopic as well as in the flow
cytometer approach, the mean fluorescence values of FITC and Rhodamine/DiD were measured
for each sample, and the autofluorescence from unlabeled samples was subtracted. The ratio
of FITC to Rhodamine/DiD was determined, and the intravesicular pH was calculated from the
standard curve.
Generation of a pH-standard curve of dextran-labeled compartments
To generate a pH-standard curve for the dextran labeled compartments, the whole cell was equi-
librated with a pre-determined pH and the resulting fluorescence ratio was measured by flow
cytometry (Bayer et al., 1998; Baravalle et al., 2005). Cells were pulsed as described above,
pelleted and divided into 7 aliquots. These were resuspended in standard pH buffers and left on
ice for 10 min for ATP depletion and equilibration of intravesicular pH (pH clamped). Figure 2.3
A shows three normalized calibration curves. In the first experiment the cells were equilibrated
without ionophore. For the other two either 10 μM nigerizin or monensin was present. The
calibration was repeated without ionophore and the resulting curve was fitted to Eq. 2.2 (Fig.
2.3 B). The obtained parameters were used to calculate the pH from the FITC/Rho ratio.
R(pH) = base+
max base
1+10((xhal f pH) rate)
(2.2)
2.2.13 Intracellular fusion assay
Influenza A/X-31 virus was diluted to 1 mg/ml in PBS -/- and labeled with 20 μMR18 for 30 min
at RT. Unbound R18 was removed by centrifugation at 50.000 g for 10 min and the virus was
resuspended in PBS. The labeled virus was diluted to 20 μg/ml in DMEM containing 0.2 % BSA,
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Figure 2.3: Generation of a pH-standard curve of dextran-labeled compartments. Cells were pulsed
as described above, washed and divided into 7 aliquots. These were resuspended in standard pH buffers
and left on ice for 10 min for ATP depletion and for equilibration of intravesicular pH (pH clamped). Dur-
ing this step there was either no ionophore or 10 μM nigerizin/monensin present. FITC and Rhodamine
signal was quantified by flow cytometry (A). The calibration was repeated without ionophore and the
resulting curve was fitted to Eq. 2.2 (B). Error bars correspond to SEM of three independent experiments.
filtered using a 0.2 μm pore size sterile filter and applied on MDCK cells in glass bottom petri
dishes. The cells were incubated on ice for 10 min, washed 3 times with cold PBS, transferred
in warm DMEM and the fluorescence was immediately followed using a confocal microscope.
Fusion was indicated by a marked increase of the R18 signal due to de-quenching during fusion
of virus envelope with the endosomal membrane. In a second assay, fusion was followed using
a double-staining protocol, as described before (Sakai et al., 2006). 100 μg viruses were diluted
in 1 ml PBS and transferred in a 2 ml round-bottom eppendorf tube. Under constant shaking
66 μM DiI and 33 μM DiO were added dropwise (6 μl each) to the virus suspension. Under
constant inverting the virus was labeled for 1 h at RT. The virus was filtered using a 0.2 μm pore
size sterile filter and applied on MDCK cells. The samples were further processed as described
above.
2.2.14 Quanti cation of the nuclear NP signal
Cells were immunostained against the viral NP and the nucleus was counterstained with DAPI
as described in section 2.2.10. Z-stacks spanning the whole cell were recorded at different
positions of the petri dish. NP and DAPI stacks were summed using Image J. A binary mask of
the nucleus was created from the DAPI image, inverted and subtracted from the NP image. The
resulting image shows only signal in the nucleus leaving the rest of the cytoplasm dark. Finally,
the summed pixel intensity of the calculated image was measured.
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2.2.15 Lectin binding assay and neuraminidase treatment
For microscopic analysis, cells were grown in glass bottom petri dishes. The cells where washed
with PBS and incubated with WGA (40 μg/ml), SNA (10 μg/ml) or MAA (50 μg/ml) for 20 min
on ice (see 2.1.3 for lectin specifications). The cells were washed in PBS and either immediately
used for confocal microscopy or incubated in fixation buffer for 30 min, washed in PBS and
mounted for microscopy. For flow cytometry, the cells were detached from the culture plate
using PBS supplemented with 2 mM EDTA for 20 - 30 min. The cells were washed in PBS and
labeled with lectins as stated above. After the final washing step, the cells were immediately
used for flow cytometric analysis. To cleave of sialic acid residues from the cell surface the cells
were incubated with 1 U/ml neuraminidase (NA) Clostridium perfringens for 10 min at 37 C.
2.2.16 Preparation of virus-coated polystyrene beads
Polystyrene (PS) beads were washed in PBS. Influenza A /X-31 was labeled with R18 as de-
scribed above. Unbound R18 was removed by centrifugation 5 min at 50.000 g and the pellet
was resuspended in PBS. The virus was diluted to 20 μg/ml in PBS and viral aggregates were
removed with a 200 nm pore size sterile filter. 5 μl beads in PBS (0.1 % solids) were added and
both were incubated for 30 min at 4 C. Unbound virus was removed by centrifugation. The
pellet was dissolved in PBS buffer containing 3 % BSA and again incubated for 30 min at RT.
Finally, the beads were washed in PBS and stored at 4 C for maximum 2 days.
2.2.17 Single Virus force spectroscopy using optical tweezers
Optical tweezers experiments were conducted at JPK Instruments AG, Bouchestrasse 12, 12435
Berlin with the help of Dr. Anna Wozniak.
For optical tweezers force measurements we used the JPK Nanotracker (Wozniak et al., 2009).
The trapping of the PS beads was performed using a 1064 nm laser at intensities between 1 -
3 W. For the calibration of the optical trap, the Brownian motion of a bead at certain laser
intensities was measured. The power spectrum of a diffusing particle in a viscous liquid, held by
a trap of stiffness k can be fitted to a Lorentzian curve (Wozniak et al., 2009). This provides the
trap stiffness k and together with the detector sensitivity the signals can be calibrated either in
nanometer displacement or piconewton forces. The value of the force of impingement, ranging
between 10 to 50 pN, was selected to promote single-bond formation between host cell surface
receptors and HA glycoproteins. Cells were seeded one day prior to the experiment kept in
growth medium. All measurement were carried out in PBS buffer at 37 C.
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2.2.18 SVFS using atomic force spectroscopy
AFM experiments were conducted in the laboratory of Prof. Peter Hinterdorfer at Johannes Ke-
pler University Linz, Institute of Biophysics, A-4020 Linz, Austria with the help of Dr. Rong
Zhu.
AFM-based force spectroscopy was performed with an Agilent 5500 AFM combined with an
iMIC microscope (TILL Photonics, Germany). Cells were seeded one day prior to the experi-
ment kept in growth medium. The glass bottom petri dish was mounted with the AFM, which
was put on the optical microscope through a specially designed XY stage. Before force measure-
ments, the cantilever with a nominal spring constant of 10 pN/nm functionalized with influenza
A/X-31 was incubated in 5 mg/ml BSA for 30 min in order to minimize the non-specific inter-
action between the cantilever tip and the cell surface. The force measurements were performed
in PBS buffer. After the cantilever tip approached to the cell surface, force distance curves were
repeatedly measured with Z-scanning range of 2 µm, cycle duration of 0.5 - 8 s, 500 data points
per curve, and typical force limit of about 40-70 pN.
2.2.19 Force Spectroscopy Data Analysis
Force-distance curves were analyzed using MatLab (MathWorks Inc.) and Igor Pro (Wave-
metrics Inc.). The loading rates were determined by multiplying the pulling velocity with the
effective spring constant ke f f , where ke f f is the slope of the force distance curve at rupture. In
the single-barrier model (Evans and Ritchie, 1997), the most probable rupture force F is given
as a function of the loading rate r:
F(r) =
kBT
xu
ln
(
rxu
ko f f kBT
)
(2.3)
Where kB is the Boltzman constant, ko f f is the dissociation rate constant of the complex
without force and xu marks the thermally averaged projection of the transition state along the
direction of the force. The parameters xu and ko f f were determined by fitting the most probable
rupture force F against the applied loading rate r.
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3 Results
3.1 Single virus force spectroscopy (SVFS)
It was one of the main aims of this study to characterize the interaction between influenza A
viruses and the cell surface at quantitative level. In order to minimally interfere with the struc-
ture of virus and cell, single molecule force spectroscopy was used as described in section 2.3.
Applying this approach to single viruses provides the advantage to investigate virus-cell binding
in a unique experimental set-up that mimics the situation on the cell surface very closely (single
virus force spectroscopy).
3.1.1 SVFS using optical tweezers.
Preparation of virus coated beads
First, it was tried to manipulate single influenza A viruses using optical tweezers. Viruses were
labeled with R18 as described in 2.2.5 and subsequently filtered using a 0.2 µm pore size filter.
The virus suspension was diluted in PBS buffer and transferred to the optical tweezers device.
After turning on the laser, the scattering signal was continuously recorded. As shown in Fig. 3.1
A, the lateral scattering signal indicates that successively viral particles entered the optical trap.
In the following, two problems occurred. First, the viruses quickly adsorbed to the cover glass
surface (Fig. 3.1 B). Second, it was not possible to control the accumulation of viruses and the
calibration of the trap holding a single virus turned out to be inaccurate. Due to the mentioned
difficulties the system was changed towards using spherical beads as virus carriers.
Polystyrene (PS) beads are frequently used as sample carriers in OT-based force spectroscopy
experiments (Mameren et al., 2011) since proteins show fast and strong adsorption on PS sur-
faces (Sagvolden et al., 1999). PS beads with a diameter of 1.5 µm were prepared as described
in section 2.2.16. At high concentration the virus particles adsorbed to the bead surface with-
out visible gaps as observed by confocal microscopy (Fig. 3.1 C). To decrease the chance of
multiple binding events the virus suspension was diluted before addition of the PS beads. The
fluorescence per bead was visualized by confocal microscopy and quantified by flow cytometry
(Fig. 3.1 D). Dilution of virus particles during the adsorption reduced the amount of bound virus
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by up to 90 %. To fill the gaps between viruses, the beads were further incubated with BSA.
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Figure 3.1: Trapping single influenza A viruses and preparation of virus-coated beads. (A) Influenza
A/X-31 viruses were labeled with R18, filtered and transferred to the optical tweezers device. After turn-
ing on the laser, successively single virus particles entered the trap, which is indicated by a stepwise
increase of the scattering signal. The trapped viruses could not be detected by eye or the installed CCD
camera (B). The position of the first (red) and secondary (white) trap laser are marked by the correspond-
ing crosses. In this study, only the primary laser trap was used. To improve the stability of the probe and
to get an accurate trap calibration, viruses were adsorbed on PS beads at different concentrations. Beads
(0.1 % solids) were incubated with 20, 5 and 0.2 μg/ml R18-labeled virus for 30 min at 4 C. The beads
were pelleted and the coating was verified by confocal microscopy (D) and quantified by flow cytometry
(C). The frame color corresponds to the respective histogram in C.
Single virus force measurements using optical tweezers
For force measurements, CHO and MDCK cells were seeded one day prior to the experiment
at a density of 1-5 105 cells per petri dish. The cells were washed and kept in pre-warmed
PBS at 37 C. The virus-coated beads were added directly to the buffer. By choosing a low cell
density, it was assured that 80-90 % of the beads sedimented on the dish surface without direct
cell attachment. In this way, the approach gave enough space to move a bead towards a target
cell from each direction. Prior to the force distance cycles the beads were trapped and moved to
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a position approx. 3-5 μm from the cell border. The distance and the speed were set and each
force-distance cycle was repeated 1-5 times. Then the bead and the position on the cell was
changed. Only very clear and sharp cell edges were selected to ensure that the bead was not in
contact with filopodia or other cell extensions. The contact force was kept between 5-50 pN and
the bead was retracted without delay to reduce the chance of multiple bindings.
Single and stepwise rupture events were detected which indicate unbinding of individual receptor-
ligand complexes (Fig 3.2 A, B). For CHO cells in most cases rupture forces of 12 pN for a
pulling velocity of 200 nm/sec were found. Very similar, for MDCK cells a maximum frequency
for 10 pN at the same retraction speed was observed. In contrast to CHO cells, on MDCK
cells a significant amount of rupture events at higher force values with a maximum at 23 pN
where found (Fig 3.2 C). This force value likely corresponds to two simultaneously rupturing
bonds. However, to increase the chance of single molecule interactions, CHO cells were used
for all further optical tweezer measurements.
Virus-cell binding was further investigated after the cells were treated with neuraminidase (NA).
After NA treatment, the size of the unbinding events was very similar compared to control cells
while the binding probability was strongly reduced by 60 - 70 % of the control level. To obtain a
force spectrum over a dynamic range, the pulling velocity v was varied between 0.5 - 10 μm/sec.
Plotting the resulting loading rate against the measured most probable rupture force revealed a
linear dependence (Fig 3.2 D). Considering the theory, this dependence indicates that a single
energy barrier is crossed in the thermally active regime (see section 2.3). Accordingly, from the
plot in Fig 3.2 D, the separation from the energy barrier xu and the kinetic off-rate constant ko f f
can be determined by fitting the curve to Eq. 1.1. The obtained values are summarized in Table
3.1.
3.1.2 Single virus force measurements using AFM
Influenza viruses from two strains A/X-31 (H3N2) and A/WSN (H1N1) were covalently at-
tached to AFM cantilevers using a bi-functional crosslinker as described in Rankl et al. (2008).
CHO, MDCK and A549 cells were seeded in glass bottom petri dishes one day prior to the ex-
periment. Suitable cells were localized using an inverted light microscope, the cantilever was
moved above the cell and lowered until touching the plasma membrane. For all cell-virus com-
binations force distance curves were recorded at pulling velocities between 0.5 - 4 μm/sec to
allow dynamic force spectroscopy analysis. Single and stepwise unbinding events were detected
indicating the rupture of individual receptor molecules (Fig. 3.3 A, B). Increasing the pulling
velocity led to an increase of the most probable rupture force with a linear loading rate depen-
dence. Fitting the dynamic force spectrum to Eq. 1.1 revealed the kinetic off-rate constant and
the separation of the bound state to the energy barrier. The obtained values are summarized in
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Figure 3.2: Single virus force spectroscopy using optical tweezers. Virus-coated beads were trapped
and moved towards an adherent cell. The speed was set and each force-distance cycle was repeated 5-10
times. Single (A) and multiple (B) unbinding events were detected (only retract curves are shown). When
the beads were blocked with BSA, no interaction was observed (A, inset). The most probable rupture
force at a pulling velocity of 200 nm/sec shows a maximum at 10 pN for CHO (red) and MDCK
cells (green). Remarkably, on MDCK cells a significant amount of rupture events happened at higher
forces with a second maximum at 23 pN (C). Variation of the pulling velocity led to a full dynamic force
spectrum with a linear dependence of the loading rate (i.e. the slope of the force curve before rupture) and
the most probable rupture force. The data points were fitted to Eq. 1.1 and revealed the separation from
the energy barrier xu and the kinetic off-rate constant ko f f . The obtained values are summarized in Table
3.1. Error bars account for the uncertainties in the determination of the spring constant and in finding the
most probable rupture force.
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Table 3.1.
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Figure 3.3: Single virus force spectroscopy using AFM. Viruses were covalently attached to AFM
cantilevers as described in (Rankl et al., 2008). The cantilever was moved above a suitable cell, lowered
and force distance cycles were recorded at various pulling velocities. Single and stepwise unbinding
events were detected (A, B), which indicates rupture of individual bonds. Increasing the pulling velocity
led to an increase of the most probable rupture force. Plotting the corresponding loading rate against the
most probable rupture force revealed a linear dependence, which could be described by Eq. 1.1. Dynamic
force spectroscopy was applied for influenza A/X-31 (H3N2) (C) and A/WSN (H1N1) virus strains (D)
using the indicated cell lines. Error bars account for the uncertainties in the determination of the spring
constant and in finding the most probable rupture force.
3.2 Whole cell-virus binding
Single virus cell binding was compared to binding on the macroscopic scale of the whole cell.
Virus-cell binding was assessed using flow cytometric quantification of R18-labeled viruses.
Viruses from both strains bound better to CHO cells compared to MDCK and A549 (Fig. 3.4).
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Table 3.1: Results obtained by fitting SMFS data in Fig. to Eq. 1.1 ko f f , kinetic off rate; xu, separation
between bound and unbound state; o f f , bond lifetime
cell method virus ko f f (s 1) xu(nm) o f f (s)
line strain
CHO OT H3N2 0.12 1.23 3.4 4.23 8.3
CHO AFM H3N2 0.18 0.17 2.6 3.11 5.5
A549 AFM H3N2 0.64 0.52 0.42 0.41 1.6
MDCK AFM H3N2 0.45 0.35 0.84 0.79 2.2
A549 AFM H1N1 1.22 0.32 0.18 0.06 0.8
CHO AFM H1N1 1.16 0.13 0.24 0.03 0.9
This interaction was dependent on SA and hence strongly reduced after NA treatment. Important
to note is that the signal per cell was normalized to the cell surface, which was calculated from
Casy counter cell diameter measurements. This allows to directly compare the three cell lines
concerning virus-cell binding.
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Figure 3.4: Fluorescence-based virus-cell binding assay. Influenza A/X-31 (A) and A/WSN (B)
viruses were labeled with R18 and incubated with the indicated cells. Unbound viruses were removed by
centrifugation and the amount of bound virus was determined by flow cytometry as the mean R18 signal
per cell. The signal per cell was normalized to the cell surface, which was calculated from Casy counter
cell diameter measurements. This allows to directly compare the three cell lines concerning virus-cell
binding. Error bars correspond to SEM of three independent experiments.
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3.3 Infection ef ciency of influenza A/X-31 viruses in A549, CHO
and MDCK cells
A successfully infecting virus must enter its host cell by endocytosis, fuse with the endosomal
membrane and deliver its genome. To find out if the initial virus-cell binding correlates with
the infection efficiency, different cell lines where incubated with influenza A/X-31 viruses and
infection was detected using anti-NP immunostaining. The NP signal per cell was visualized
by confocal microscopy and quantified by flow cytometry (Fig. 3.5). At a MOI of 10-20, 5 h
post-infection 90 % of MDCK cells were infected displaying strong nuclear anti-NP signal. The
infection was lower in CHO cells and reached only 65 %. The lowest infection was detected in
A549 cells, where only 22 % of the cells where infected.
In a competition experiment MDCK and CHO cells were mixed and seeded at 2 different ratios
in the same dish and subsequently infected with influenza A/X-31. Successful infection was
detected by immunostaining of NP. This was done to directly compare the infection efficiency
of two cell lines with different SA-coupled receptors on their plasma membrane in the same
sample. Fig.3.6 shows confocal micrographs of two cell ratios: MDCK:CHO of 2:1 (upper
row) and 1:3 (lower row). In order to discriminate between the two populations, the cells were
stained with the fluorescent lectin SNA-FITC, which binds -2,6-linked SA. This carbohydrate
is not present on CHO cells and thus only MDCK cells were labeled and can be discriminated.
Between 60 - 80 % of MDCK cells were infected in both samples. In contrast, CHO cells were
infected to a much lesser extend of only about 10 - 20 %, which corresponds to less infected cells
than in the experiment with only one cell line (Fig. 3.5). This experiment verifies that although
CHO cells bind more viruses than MDCK cells, their infectivity is strongly reduced and that this
effect is still present and even more pronounced when both cells grow side-by-side.
3.4 Cell surface topography and sialic acid composition of A549,
CHO and MDCK cells
Influenza A viruses have a certain receptor specificity, which is determined by the amino acid
composition of the receptor binding site (see 1.1.3). Human and avian type receptors are com-
posed of sialic acid coupled to lactose (sialyllactose). While within the human type receptor both
sugars are connected via a -2,6 glycosidic linkage, in the avian type a -2,3 glycosidic linkage
is existent. To characterize the used cell lines concerning their surface SA composition, specific
fluorophore-conjugated lectins were used to discriminate between -2,6 and -2,3 connected
SA. The cells were labeled with fluorophore-conjugated WGA (binds all SA), SNA ( -2,6) and
MAA ( -2,3) to quantify the overall amount of SA on the cell surface as well as to characterize
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Figure 3.5: Infuenza A/X-31 infection efficiency of A549, CHO and MDCK cells. The efficiency of
influenza A/X-31 virus to infect different cell lines was measured by immunostaining of the viral NP.
Cells were infected at a MOI of 10-20 and stained 5 h post-infection. The production of viral NP was
visualized by confocal microcopy and quantified by flow cytometry. Cells with a NP signal above the
background fluorescence were considered as infected. Scale bar 10 µm. Error bars correspond to SEM of
three independent experiments.
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3.4 Cell surface topography and sialic acid composition of A549, CHO and MDCK cells
DAPI / SNA / NP
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Figure 3.6: Infuenza A/X-31 infection efficiency of CHO and MDCK cells growing side-by-side. The
efficiency of influenza A/X-31 virus to infect CHO and MDCK cells growing side-by-side was measured
by immunostaining of the viral NP. Two different MDCK:CHO ratios of 2:1 (A) and 1:3 (B) were used.
Cells were infected at an MOI of 10-20 and stained 5 h post-infection. The cells were co-stained with
the fluorescent lectin SNA-FITC, which marks -2,6-linked SA. Since CHO cells do not express this
particular glycan, only MDCK cells were labeled and could be discriminated. Scale bar 30 μm.
53
3 Results
the specific SA linkage. The cells were analyzed by confocal microscopy and flow cytometry.
Fig. 3.7 shows confocal micrographs of A549, CHO and MDCK cells stained with either WGA
or MAA and SNA. While A549 and MDCK cells present both types of SA linkage, CHO cells
only present -2,3 linked SA. The flow cytometric analysis of the WGA signal shows that all
three cell lines possess equal amounts of surface sialic acid (Fig. 3.8A). Because CHO cells
(diameter 13 μm) are much smaller than MDCK (diameter 19 μm) and A549 cells (diam-
eter 20 μm), to get information about the SA surface density, the fluorescence signals were
normalized to the cell surface.
Flow cytometric analysis of SNA/WGA labeling confirmed the microscopic observations that
A549 and MDCK cells present both types of SA linkage while CHO cells do not present -2,6
linked SA (Fig. 3.8). The surface sialic acid content was assessed after treating the cells with
neuraminidase from Clostridium perfringens, an enzyme which hydrolyzes -2,6 as well as -
2,3 glycosidic linkages of terminal sialic acid residues. Treating the cells with NA reduced the
amount of surface sialic acid by 50 - 90 % on all three cells lines. Further, NA treatment reduced
both SNA and MAA signals, indicating that both types of SA linkage where cleaved (Fig. 3.8B).
The cellular topography was analyzed by scanning electron microscopy (SEM)1. Fig. 3.9 and
3.10 show SEM micrographs of A549, CHO and MDCK cells at 2 different confluency states.
In Fig. 3.9 the cells were analyzed at low confluency of 50 - 70 %. A549 and MDCK cells
appear very flat, while CHO cells have a higher curvature. All cell lines already display a high
amount of cellular protrusions (microvilli), which vary in number and size. On A549 and CHO
cells about 1-5 microvilli per μm2 were counted. These have a length of 0.5-1 μm and are
100 nm in diameter. In contrast, on MDCK cells 5-10 microvilli with length of 0.2-0.5 μm and
a diameter of 100 nm were detected per μm2. The cells in Fig. 3.10 were imaged at full
confluency. The size of microvilli is similar compared to low confluent cells, but the number
increases for A549 and MDCK cells. On A549 cells 5-10 and on MDCK cells 10-20 microvilli
are visible per μm2. Interestingly, MDCK cells form a compact cell layer in which individual
cells are hardly visible. A549 cell grow dense, but with space between individual cells. CHO
cells loose shape and grow on top of each other.
3.5 Conclusions from 3.1 - 3.3
The interaction of influenza viruses with the plasma membrane of living cells was characterized
on the level of single molecules as well as on the whole virus-cell level. By choosing cell lines
with different SA repertoire on their surface, it was possible to study virus binding to human
1 SEM sample preparation and image acquisition were conducted by Katharina Horst during her BA work under
my supervision in the lab of Dr. Maik Lehmann.
54
3.5 Conclusions from 3.1 - 3.3
SNA MAAWGA
CH
O
A5
49
M
DC
K
Figure 3.7: Confocal microscopy of lectin binding to A549, CHO and MDCK cells. A549, CHO
and MDCK cells were washed in PBS and incubated with the fluorescent lectins FITC-WGA (40 μg/ml),
Rho-MAA (50 μg/ml) or FITC-SNA (10 μg/ml) for 20 min on ice. The cells were washed with PBS
and analyzed by confocal microscopy. All used cell lines present a high degree of sialic acid. A549
and MDCK cells feature -2,6 as well as -2,3-linked SA on the cell surface. In contrast CHO cells
exclusively present -2,3 linked SA. Scale bar 10 μm.
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Figure 3.8: Flow cytometric quantification of lectin binding to A549, CHO and MDCK cells. A549,
CHO and MDCK cells were detached from the culture flask surface using PBS -/- supplemented with 2
mM EDTA. The cells were washed in PBS and incubated with the fluorescent lectins FITC-WGA (40
µg/ml), Rho-MAA (50 µg/ml) or FITC-SNA (10 µg/ml) for 20 min on ice. The cells were washed in
PBS, pelleted (2000 g, 5 min) and resuspended in 300 µl PBS buffer and immediately analyzed by flow
cytometry. Error bars correspond to SEM of three independent experiments.
and avian type receptors. The used influenza virus strains A/X-31 and A/WSN did not exhibit a
strong receptor specificity in SVFS, meaning they did not favor binding to either the human or
avian type receptor. Further, the single SA-HA interaction was found to be very weak. There-
fore, virus-cell binding probably depends on multiple simultaneous interactions. This binding
mode provided the basis for the design of a variety of multivalent SA-functionalized nanopar-
ticles made to mimic the cell surface to efficiently prevent virus-cell binding. Due to the small
differences in preferential virus binding, the nanoparticles were coated with SA without addi-
tional carbohydrates. Furthermore, due to the unnatural linkage this approach has the advantage
that SA can not be cleaved by viral NA. In the next section the results of influenza virus activity
measurements under the influence of multivalent nanoparticles are described.
3.6 Inhibition of influenza virus activity using multivalent
nanoparticles
Two species of particles were utilized as summarized in 2.1.5. Organic polyglycerol (PG) par-
ticles were used at two size ranges of 3 nm (PG 1-3) and 50-70 nm (PG 4-5) as well as varying
SA surface content (see Table 2.1.5). As a second nanoparticle system, gold colloids with a
diameter of 2 and 14 nm coated with SA were used. The particles were tested for their ability
to bind HA and to inhibit HA-associated events during influenza virus infection. The results are
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Figure 3.9: Scanning electron microscopic analysis of the cellular topography of A549, CHO and
MDCK cells at low confluency. Approximately 5 105 A549, CHO and MDCK cells were seeded in
glass bottom petri dishes. After 24 h the cells had reached 50-70 % confluency. The cells were washed
three times in PBS and incubated in fixation buffer for 30 min. After another 3 washing steps in PBS the
cells were prepared and analyzed by SEM. Scale bar 5 μm (left) and 1 μm (right).
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Figure 3.10: Scanning electron microscopic analysis of the cellular topography of A549, CHO and
MDCK cells at full confluency. Approximately 5 105 A549, CHO and MDCK cells were seeded in
glass bottom petri dishes. After 24 h the cells had reached full confluency The cells were washed three
times in PBS and incubated in fixation buffer for 30 min. After another 3 washing steps in PBS the cells
were prepared and analyzed by SEM. Scale bar 5 μm (left) and 1 μm (right).
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illustrated in the next section.
3.6.1 Inhibition of influenza virus activity using multivalent polyglycerol (PG)
particles
Inhibition of virus-cell binding
First, the ability of the PG constructs to act as competitive inhibitors of virus-erythrocyte bind-
ing was investigated. To this end, R18-labeled viruses and washed human erythrocytes were
incubated for 30 min before unbound virus was removed by centrifugation. The amount of
bound virus per erythrocyte was quantified by flow cytometry as the mean R18 intensity per
cell. To study the inhibitory activity of PGs, viruses were pre-incubated with PGs 1-5 (see Ta-
ble 2.1.5) in varied concentrations. Fig. 3.11A summarizes the results of binding experiments.
To express the effect of multivalency, monovalent SA was used as an inhibitor reference in all
experiments. Accordingly, the amount of PGs is expressed as concentration of SA equivalents.
The monomeric SA had no effect on viral adhesion between 400 µM and 4 mM. In contrast, pre-
incubation of influenza virus with sialic acid functionalized PGs 1-3 led to a strong reduction
of the fluorescence signal per erythrocyte. Binding was inhibited to 50 % of the control level at
approximately 3 mM PG but significant reductions in virus binding were only observed above 1
mM. There was no strong difference between PGs 1-3 with varied degrees of functionalization.
The distribution displays a rather linear dependence of SA concentration at least in the studied
range. On a per sialic acid basis, PG 4 (dF 12 %) reached 50 % inhibition already at concentra-
tions 40-fold lower than the small PGs. This leads to a markedly exponential increase in binding
strength with greater particle size and number of multivalent binding units. In comparison, PG
5 (dF 80 %) showed weaker binding and did not reach 50 % inhibition in the used concentration
range. Notably, the sulfated PG had only a minor inhibitory effect at concentrations above 1
mM, emphasizing the importance of SA as a specific ligand for HA.
Inhibition of HA-mediated virus-cell fusion
The ability of influenza A/X-31 virus to undergo fusion was investigated using fluorescence de-
quenching of R18 upon fusion of labeled viruses with erythrocyte ghost membranes.
Viruses were labeled with R18 at self-quenched concentration, bound to RBC ghosts and fusion
was triggered by addition of citric acid (0.2 M). The results are presented in Figure 3.11 B. The
monomeric form of SA had a small effect on the fluorescence de-quenching and reduced the
extent of fusion by 15 % at the highest measured concentration of 4 mM. However, all tested
sialic acid functionalized polymers had a more pronounced effect on virus fusion. PGs 1-3
reduced the extent of fusion to 35 % at 4 mM sugar equivalents; 50 % inhibition was achieved
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Figure 3.11: Fusion and binding efficiency of influenza A/X-31 virus after pre-incubation with
multivalent PG inhibitors. Relative binding (A) and fusion (B) efficiency of X-31 virus to human
red blood cells dependent on the inhibitor concentration. Viruses were pre-incubated with the indicated
inhibitor concentration (SA equivalents) for 30 min at RT and subsequently used for binding and fusion
quantification. Error bars correspond to SEM of three independent experiments.
at approximately 2 mM sugar equivalents. No significant differences were observed within the
small PG series 1-3, which differ only by their dF. Similar to binding inhibition, PG 4 was most
effective, causing almost total inhibition at 4 mM SA equivalent concentration; 50 % inhibition
could be achieved below 100 μM. On a per sugar basis, PG 5 was found to be approximately
20-fold more effective than the small PG series at causing 50 % inhibition. Again, the sulfated
polymer showed no effect.
Notably, the fusion assay reflects the fusion of all bound viruses whose number was also strongly
reduced (Fig. 3.11 B). For instance, PG 5 reduced the binding by 40 % at 1 mM. The same
concentration reduced the fusion by 20 %. This means that only 50 % of the viruses were able
to bind and fuse for this particular case.
Inhibition of infection
For a successful infection, the virus has to enter via endocytosis and deliver its genomic material
after fusion with the endosomal membrane. To investigate if the PG polymers have an impact on
infectivity, unlabeled viruses were incubated with different amounts of polymers and exposed
to MDCK cells at a multiplicity of infection (MOI) of 25. The production of viral proteins is
a clear sign for a successful infection. Accordingly, the production of viral NP was assessed
by immunofluorescence microscopy and flow cytometry using anti-NP antibodies. Using both
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techniques, six hours post-infection NP protein signal could be detected in 80-90 % of the cells
which indicates a positive infection (Fig. 3.12 A). At this stage of infection a strong nuclear and
some cytoplasmic signal was observed. Compared to the background fluorescence of uninfected
cells, this allowed a clear identification of infected cells. Using viruses treated with 1 mM
PG 3, NP signal was detected in 20 % less cells compared to the control (Fig. 3.12 B). At a
concentration of 1 mM PG 4, the amount of infected cells was even reduced to 20 % of the
control level. An increase of the concentration to 4 mM led only to a small increase of inhibition
( 15 % of control level). The fluorescence per cell was quantified by flow cytometry and
allowed to deduce the infection level (Fig. 3.12C).
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Figure 3.12: Infection efficiency of influenza A/X-31 virus after pre-incubation with multivalent PG
inhibitors. MDCK cells were infected with influenza A/X-31 virus without (A) and after pre-incubation
with 4 mM PG 4 (B). Positive infection was detected by immunostaining of the viral NP. The production
of viral NP was visualized by confocal microcopy and quantified by flow cytometry (C). Cells with a
NP signal above the background fluorescence were considered as infected. Scale bar 10 μm. Error bars
correspond to SEM of three independent experiments.
Cell viability after treatment with SA-conjugated polyglycerol particles
The cell toxicity is an important parameter within the evaluation of synthetic antiviral test sub-
stances. To verify that the used polyglycerol particles are biocompatible, the cell viability was
assessed after treating the cells with different concentrations of SA-conjugated polyglycerols as
well as monomeric sialic acid. As shown in Fig. 3.13, the cells were treated with 4 and 1 mM
PG (SA concentration) as well as monomeric SA. 4 mM PG reduced the cell viability by 20%.
Interestingly, the same concentration of monomeric SA led to an increase of the signal. The
lower 1 mM concentration of SA-PG, SA and the control polymer (PM OH) had only very little
effects on cell viability.
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Figure 3.13: Cell viability after treatment with PGs and monovalent SA. MDCK cells were incubated
with SA-conjugated polymers, OH-precursor polymer and monovalent SA. After 4 hours, the cells were
treated with Celltiter Blue for an additional hour before the cell viability was fluorometrically quantified
via the metabolically produced resorufin as described in 2.2.2. Error bars correspond to SEM of three
independent experiments.
3.6.2 Inhibition of influenza virus activity by multivalent sialic acid functionalized
gold particles (AuNP)
In a second nanoparticle-based approach, gold was used as a carrier for sialic acid, which was
attached via thiol-coupling as a dendrimer with four terminal SA moieties (Papp et al., 2010).
Due to the strong interference of gold particles with organic fluorophores (Schneider et al.,
2006; Hazarika et al., 2006), it was not possible to use the R18-based binding assay described
before. Therefore, the ability of influenza virus to bind target membranes was tested by mea-
suring the virus-induced agglutination of red blood cells (HAI). HAI is a widely used method to
evaluate inhibitors of influenza virus binding. The assay measures the lowest concentration of
inhibitor that still prevents hemagglutination which is defined as KHAI.
Unlabeled influenza A/X-31 viruses were mixed with 2-fold dilutions of AuNPs and allowed
to pre-incubate for 30 min at RT. RBCs were added and the system was incubated for another
hour at RT. SA conjugated AuNPs inhibited hemagglutination at KHAI in the nM range (Fig.
3.14). In contrast, the 2 nm particles had no effect on virus-induced agglutination of RBCs. This
demonstrates that the potential of multivalent inhibitors clearly depends on the particle radii and
thus on the spacial distribution of the interacting ligand/receptor pairs.
To test whether AuNPs directly bind to HA, HA coupled to a yellow fluorescent protein (HA-
YFP) was expressed in CHO cells. Gold nanoparticles quench organic fluorophores by a mech-
anism that is not yet fully understood (Schneider et al., 2006; Hazarika et al., 2006). AuNPs
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( ≈ 0 5M) were mixed with 5 ∗ 105 HA-YFP expressing cells and incubated for 30 min. The over-
all YFP emission was measured in a fluorescence spectrometer between 500 and 600 nm ( λ ex =
490 nm). Without washing the YFP emission was reduced by ≥ 60 % (Fig. 3.15 A). If the com-
plex was washed once in PBS after the first incubation only 20 % reduction were achieved (Fig.
3.15 B). As a negative control, the same experiment was done using the hydroxylated control
AuNP. Here, the YFP emission was reduced only by 5 and 10 % respectively, which indicates
specific binding of SA-AuNP. However, since the effect was strongly reduced upon washing the
cells in buffer, the binding seemed to be weak.
Au-NP OH
Au-NP SA
1:2 1:4 1:8 1:321:16 1:64
Figure 3.14: Inhibition of hemagglutination (HAI) by influenza A/X-31. The virus was pre-treated
with SA- and control OH-AuNPs for 30 min before addition of RBCs. AuNPs were sequentially diluted
by a factor of 2 in PBS. If agglutination was inhibited, the RBCs sedimented to the bottom of the well
and formed a pellet (see Fig. 2.1). Otherwise, they were crosslinked by the virus particles and formed a
gel.
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Figure 3.15: Fluorescence emission spectra of HA-YFP transiently expressed in CHO cells. Cells
expressing HA-YFP in suspension were mixed with SA- and OH- conjugated AuNPs. Emission spectra
were recorded directly after 30 min incubation time (A) and after an additional washing step (B) at λ ex =
490 nm between 500 and 600 nm.
One advantage of using gold as a carrier is the strong contrast in transmission electron mi-
croscopy (TEM). From the size of the particles one can deduce a possible binding mode. Re-
garding the diameter of an HA trimer (7 nm), the 2 nm particles can only bind to one trimer.
The larger 14 nm particles can presumably bind to more than one trimer. In order to test this
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binding hypotheses, both SA-conjugated AuNP species were used for binding studies and sub-
sequent TEM visualization 2. To avoid the influence of negative staining chemicals on binding,
cryogenic-TEM was used for the visualization of AuNP binding. In this approach the sample is
vitrified using liquid ethane. Figure 3.16 shows influenza A/X-31 viruses incubated with 2 nm
SA AuNPs. Due to the similar size of the HA trimers seen from above, the particles are only
clearly detectable in the side view projection (Fig. 3.16 B, arrows). In contrast, the larger 14
nm particles can easily be identified and show binding of multiple HA trimers. This verifies the
previously concluded binding architecture and might explain why 2 nm particles are not able to
inhibit hemagglutination.
A
B
C
Figure 3.16: Cryo-TEM visualization of AuNP binding to influenza A/X-31. 2 and 14 nm SA-
conjugated AuNPs were incubated with influenza A/X-31 virus for 60 min at RT and then prepared for
cryo-TEM. The 2 nm particles are only visible in side view projections. In contrast, the 14 nm particles
can be easily identified. Both particle types bind to the used influenza A/X-31 virions. Scale bar 50 μm.
Finally, the ability of AuNPs to inhibit viral infection was tested. The virus was pre-incubated
with SA- and control-AuNPs for 30 min. Subsequently, the virus was exposed to adherent
MDCK cells at a MOI of 10-20 at 37 C. Five hours post-infection, the cells were fixed and
immunostained against viral NP to measure the extent of successful infection. The expression
of viral NP was quantified by flow cytometry. 80 - 90 % of the control cells (absence of AuNPs)
showed an increased NP signal indicating successful infection (Fig. 3.17). The virus incubated
with SA-AuNP reduced the infection by 40 %, while the control OH-AuNP led only to a reduc-
tion of 20 %.
2Cryo-TEM sample preparation and image acquisition were performed by Dr. Kai Ludwig, Research Center of
Electron microscopy, Freie Universität Berlin.
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Figure 3.17: Infection efficiency of influenza A/X-31after pre-incubation with AuNPs. Cell viability
in the presence of AuNPs. Influenza A/X-31 viruses were pre-incubated with SA- and OH-conjugated
AuNPs and applied to MDCK cells. The cells were fixed and stained for viral NP 5 h post-infection. The
NP signal per cell was quantified by flow cytometry (A). While the negative control shows the background
fluorescence, the positive control includes cells infected with untreated virus. Cells with a NP signal
above the background fluorescence were considered as infected (B). Cell viability was measured using PI
staining (B). Error bars correspond to SEM of two independent experiments.
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It was essential to examine the cell toxicity of the used AuNPs. MDCK cells were incubated
in the presence of AuNPs for six hours. The cells were detached and labeled with the DNA-
intercalating fluorescent dye, propidium iodide (PI) which is membrane-impermeable and hence
excluded from vital cells. In contrast, injured and dead cells become efficiently stained by the
probe as indicated by an intense fluorescence signal. Figure 3.17 B shows that the cell viability
was maintained close to 100 % compared to the untreated control cells.
3.6.3 Conclusions from 3.6
The previous section described how synthetic particles mimicking the cell surface in terms of
sialic acid presentation can efficiently prevent virus-cell interaction. Differently sized particles
with diverse degrees of functionalization were tested and showed that both parameters indeed
play a pivotal role in virus binding. While the degree of functionalization does not play an
apparent role for small particles, it becomes much more important when the particles get in the
size range of the virus. The presented PGs with sizes similar to that of the virus inhibit its activity
in vitro by 80%. However, in the presence of inhibitory nanoparticles, viruses were still able
to infect cells. In the next section the first steps of influenza A virus cell infection starting from
virus entry were studied in order to characterize this fundamental phase of infection and identify
possible points for targeted antiviral strategies.
3.7 Intracellular traf cking and fusion of influenza A virus in MDCK
cells
3.7.1 Influenza A/X-31 virus is rapidly transported within the endo-/ lysosomal
degradative pathway
Upon endocytosis, influenza A virus is rapidly transported to early endosomal compartments. To
visualize the time scale of these events, MDCK cells were transfected with endosomal marker
proteins. The small GTPases Rab5 and Rab7 are well characterized markers for early and late
endosomes respectively (Huotari and Helenius, 2011). Early endosomes associate only with
Rab5. During the endosomal maturation, Rab5 and its effectors are replaced by Rab7, which
is then present on late endosomes and lysosomes. Since this is a gradual process, intermedi-
ate/maturing endosomes (ME, multivesicular bodies) carry both proteins.
MDCK cells were transfected with Rab5-GFP and Rab7-CFP 16 h prior to the experiment. To
simultaneously follow the viruses, their viral envelope was labeled with R18. Figure 3.18 shows
a timeline of the intracellular virus transport. Upon internalization, the virus reaches early endo-
somes after about 5 min. At 10 min, the virus-containing endosomes show already Rab7 signal
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which indicates ME localization. The viruses co-localize with both Rab proteins until 30 min.
As previously shown, a gradual decrease of Rab5 goes along with a gradual increase of Rab7
(Rink et al., 2005). In addition, a gradual increase of the endosome size was observed. After
30 min the virus-containing endosomes show only Rab7 signal. Taken together, these results
show that the virus is rapidly transported after internalization and reaches late endosomes after
30 min.
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Figure 3.18: Endosomal localization of influenza A/X-31 viruses after endocytosis. MDCK cells were
transfected with Rab5-GFP / Rab7-CFP and infected with R18-labeled viruses. Viruses were adsorbed
on ice for 10 min, washed and transferred into pre-warmed growth medium. The cells were immediately
followed by confocal microscopy at 37 C. Scale bar 10 μm.
3.7.2 Intracellular fusion of influenza A/X-31 virus detected by R18 - dequenching
R18 labeling provides an advantage, that was used before to study virus-ghost fusion. The high
concentration of the fluorophore in the viral envelope leads to strong self-quenching, which will
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be releaved upon fusion and dilution of the dye into the endosomal membrane. To illustrate this,
Fig. 3.19 shows R18-labeled viruses (spots) at 0 (A) and 20 min (B) post-infection. Some of the
R18 spots show a strong signal increase, which indicates de-quenching due to virus-endosome
fusion (D). This effect was much less pronounced when the endosomal acidification was inhib-
ited by the presence of 20 μM bafilomycin A (BafA) during the experiment. This indicates that
indeed intracellular fusion of influenza A viruses can be measured using R18 labeling. Spon-
taneous probe exchange due to the close proximity of viral envelope and endosomal membrane
was very low, as shown by BafA treatment (Fig. 3.19 C, D).
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Figure 3.19: Intracellular fusion of influenza A/X-31 virus can be detected using R18 labeling.
MDCK cells were infected with influenza A/X-31 viruses labeled with R18 at self-quenched concentra-
tions. The viruses were adsorbed on ice for 10 min. The cells were washed three times with cold PBS,
transferred into pre-warmed growth medium and immediately observed using a confocal microscope. The
cells were kept at 37 C throughout the experiment. Stacked images of untreated cells were acquired at 0
(A) and 20 min (B) post-infection. To estimate the amount of spontaneous R18 exchange, the endosomal
acidification was blocked using 20 μM BafA. Images were taken after 20 min (C). The R18 spots marked
with an arrow head (A-C) were quantified using a line plot measurement (D). Scale bar 10 μm.
To gain insights into the kinetics of intracellular fusion, MDCK cells were infected with R18-
labeled viruses and the fluorescence was followed over 60 min. At every time point, image stacks
of the whole cell were acquired, summed and analyzed using the software Localize (Thompson
et al., 2002). The software identifies and measures the size and intensity of individual R18 spots.
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The results are shown in Fig. 3.20 A. Interestingly, the mean spot signal immediately increases
within the first 5-10 min, suggesting early endosomal localization at the time of fusion. Infec-
tion of Rab5/Rab7 expressing cells verified this notion. Fig. 3.20 D shows an example of an
R18-labeled virus with high intensity co-localizing with Rab5 without Rab7. However, these
events were only rarely observed.
The reliability of the R18-based assay was further tested using a different labeling technique
introduced by Sakai et al. (Sakai et al., 2006). This approach makes use of two fluorophores
DiO and DiI with overlapping excitation and emission spectra. This allows Foerster Resonance
Energy Transfer (FRET) due to the close proximity of both dyes within the viral membrane.
Upon fusion, FRET as well as self-quenching will be reduced, which can be quantified by cal-
culating the ratio between DiO and DiI. Figure 3.20 C shows double labeled viruses at different
time points post-infection. On the first images, 2 min after infection, the viruses appear red due
to self-quenching of DiO as well as FRET to DiI. At 15 min post-infection an increase of the
DiO signal became visible, which results in a yellow appearance of the virus spots. After 25
min, the viruses became green with only a little fraction of red fluorescence. In each image the
red and green signal of each visible virus spot were quantified and the ratio calculated (Fig. 3.20
A). The kinetics are very similar as measured using R18 de-quenching.
The fusion kinetics were further studied in cells treated with BafA. Treatment led to a linear
increase of the R18 signal (Fig. 3.20 B), indicating a very low probe exchange in the absence of
fusion.
To study if the described intracellular fusion assay is robust against variable virus concentrations,
the fusion kinetics were investigated using different MOIs. The cells were treated as described
and followed over 60 min (Fig. 3.21A). The kinetics of fusion were similar and were thus as-
sumed not to depend on the MOI in the investigated regime.
It was previously shown by the group of Zhuang (Rust et al., 2004; Lakadamyali et al., 2006,
2003) that influenza viruses are rapidly transported along microtubules towards the perinuclear
region (PNR) before fusion occurs. Figure 3.21 shows the kinetics of fusion in untreated cells
and cells treated with the microtubule disrupting drug nocodazole. In untreated cells, the R18
signal rises immediately with = 10 min. The signal saturated already after 25 min. In noco-
dazole treated cells, the R18 fluorescence showed a delayed increase (Fig. 3.21 B). The time
constant increased to = 32 min. The overall growth of the R18 signal which is the sum of all
individual de-quenching events per cell was reduced by about 30% in nocodazole treated cells
without saturation in the observed time range.
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Figure 3.20: Intracellular fusion kinetics of influenza A viruses using R18-only and double-
fluorophore labeling. R18-labeled viruses were adsorbed to MDCK cells on ice for 10 min. Afterwards,
the cells were washed 3 times with cold PBS, transferred into pre-warmed growth medium and imme-
diately observed using a confocal microscope. The cells were kept at 37 C throughout the experiment.
Stacked images were acquired over 60 min and the fluorescence of each R18 spot was quantified using
the software Localize (Thompson et al., 2002) (A). Shown are the mean R18 intensities of all detected
spots of 3-5 image stacks per time point. In a second approach, viruses were labeled with DiO and DiI,
which allows to detect fusion via de-quenching and FRET. Upon fusion, reduced FRET from DiI to DiO
as well as de-quenching of DiI can be observed (C). This results in an increase of the DiO/DiI ratio (A).
The kinetics are essentially the same, which verifies the results from R18 labeling. Further, the effect of
the H+-ATPase inhibitor bafilomycin A (BafA) was tested. BafA inhibits fusion and allows to observe
spontaneous probe exchange, which had a linear time dependence and remained low compared to fusion-
induced R18-dequenching. D shows a summed image stack of a Rab5/7 co-expressing cell infected with
R18-labeled viruses. The arrow head marks a fusion event that co-localizes with Rab5 but not Rab7.
Scale bar 5 μm.
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Figure 3.21: Intracellular fusion kinetics of influenza A virus in MDCK cells do not depend on the
used MOI but on intact microtubules. MDCK cells were infected as described before using different
amounts of viruses (A). R18-labeled viruses were adsorbed on ice for 10 min, the cells were washed
and transferred into pre-warmed growth medium. The cells were immediately followed by confocal
microscopy over a period of 60 min. In another experiment MDCK cells were pre-treated with 50 μM
nocodazole for 30 min. The cells were infected as described, with nocodazole present throughout the
experiment.
3.7.3 Virus-endosome fusion mostly occurs in the perinuclear region (PNR) and
depends on an intact microtubule network
As shown in the previous section, the kinetics of fusion are influenced by the presence of the mi-
crotubule disrupting drug nocodazole leading to slower fusion and reduced R18 de-quenching.
In a next step, the subcellular localization of the fusion events was analyzed. The cell nuclei
were stained with Hoechst and the cell boundary was deduced from the brightfield microscopic
image. The cytoplasm was divided into two parts. The area within 2 μm around the nucleus
was regarded as the PNR, the rest of the cytoplasm as cell periphery. Figure 3.22 summarizes
the results of the fusion localization analysis. In untreated cells, 75 % of the fusion events were
localized in the PNR. This prevalence was balanced after nocodazole treatment (Fig. 3.22 C).
The fusion events were randomly distributed in the cytoplasm and 55 % were found to be in the
PNR. Remarkably, the total number of fusion spots per cell was only very weakly affected (Fig.
3.22 D).
In order to relate the localization of fusion events with the success of infection, cells were in-
fected in the presence and absence of nocodazole. Infection was visualized by immunostain-
ing of the viral NP. Figure 3.23 shows MDCK cells infected with influenza A/X-31 virus 5 h
post-infection. All of the untreated cells show NP signal in the nucleus (A). In contrast, after
nocodazole treatment, the NP signal was reduced by 40 - 60 % (B).
The distance to the nucleus can be maximized using an acid-mediated by-pass of endocytosis,
to circumvent endosomal uptake and transport of viruses. This was achieved by adding cell
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fusion buffer to cells with bound virus, thus inducing fusion of the viral envelope directly with
the plasma membrane (Helenius et al., 1980). Influenza A/X-31 viruses were bound to MDCK
cells on ice for 10 min. The cells were washed with cold PBS and virus fusion with the plasma
membrane was triggered using cell fusion buffer. Fusion was allowed to proceed for 5 min at
37 C. Afterwards, the cells were washed and either directly fixed or incubated for the indicates
times.
Figure 3.24 A and B shows MDCK cells at 0 and 20 min after acid by-pass stained with poly-
clonal H3N2 and NP antibodies. After zero minutes, the virus particles are well labeled, while
only in very rare cases NP signal could be detected. At 20 min post-fusion, punctate NP signals
are visible in the cytosol. This indicates that the viral genome was successfully released after
plasma membrane fusion. At 5 h post-fusion successful vRNP nucleus-import can be detected
by newly produced NP accumulation in the cell nucleus (Fig. 3.24 C). The nuclear NP signal
was quantified and revealed a 50-70 % lower signal compared to untreated cells (Fig. 3.24 D).
3.7.4 Influenza A/X-31 virus delays the endosomal acidi cation to ensure optimal
residence time in early and late endosomes.
The time point of virus fusion and hence its intracellular localization essentially depends on
the endosomal pH. The pH threshold of influenza A/X-31virus fusion was determined using
virus-ghost fusion. Additionally, in a similar set of experiments the threshold of HAs conforma-
tional change was probed using the polarity sensitive fluorophore bis-ANS (Korte and Herrmann,
1994). Figure 3.25 A shows that the fusion activity of influenza A/X-31 virus starts already at
around pH 6. The bisANS signal increased earlier immediately below pH 7 (Fig. 3.25 B). This
is not necessarily an indication for the conformational change of HA. Some of the bisANS signal
must be attributed to other parts of the virus apart from HA since pH-inactivated virus gave a
signal as well. However, still the signal starts to rise at pH above 6. Taken together, these exper-
iments indicate that virus-endosome fusion starts already at subacidic pH, which corresponds to
the pH of early endosomes (see 3.7.2) and reached its maximum at pH 5.4.
But how does the virus ensure perinuclear localization at the time point of fusion? The intra-
endosomal pH was monitored in the presence and absence of an influenza virus using a combina-
tion of a pH sensitive and an insensitive fluorophore. Endosomes without virus were loaded with
FITC/Rhodamine-labeled dextran and the fluorescence of both dyes was followed over 30 min.
If a virus was co-internalized, the virus was labeled with DiD and mixed with FITC-dextran
prior to incubation with the cells. Stacked images were recorded, summed and searched for
endosomes that could be re-found between the time points (Fig. 3.26 A). Without virus, the en-
dosomal pH drops very quickly reaching a pH around 6 after 10 min (Fig. 3.26 B, C). If a virus
was co-internalized the acidification was delayed and reached pH 6 only after 30min. The intra-
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Figure 3.22: Nocodazole treatment leads to randomly localized fusion of influenza A/X-31 viruses in
MDCK cells. MDCK cells were pre-treated with 50 μM nocodazole for 30 min. Viruses were adsorbed
on ice for 10 min, the cells were washed and transferred into pre-warmed growth medium. The cells
were immediately followed by confocal microscopy. The dashed line represents the cell boundaries,
determined from the brightfield microscopic image. The DNA staining is shown in red. The fusion
sites per cell were counted and classified by their location (C, D). In untreated cells, 75 % of the fusion
events were localized within the PNR (A, C). In contrast, nocodazole treatment almost balanced this
prevalence leaving only 55 % in the PNR (B, C). Interestingly, the number of fusion events was only very
weakly affected (D). Scale bar 10 μm. Error bars correspond to SEM of 20 cells from three independent
experiments.
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Figure 3.23: Infection efficiency of influenza A/X-31 virus in MDCK cells treated with nocodazole.
MDCK cells were pre-treated with 50 µM nocodazole for 30 min. The cells were infected with influenza
A/X-31 virus and immunostained using anti NP antibodies 5 h post-infection. In untreated cells (A) all
nuclei show a clear NP signal. In contrast in cells treated with nocodazole (B) the nuclear signal was
reduced by 40 - 60 %. Scale bar 20 µm.
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Figure 3.24: Genome release and infection after plasma membrane fusion (acid by-pass) of in-
fluenza A/X-31 virus with MDCK cells. Influenza A/X-31 virus was bound to MDCK cells on ice for
10 min. The cells were washed 3 times in cold PBS and transferred into pre-warmed cell fusion buffer.
Fusion was allowed to proceed for 5 min, during which the cell dish was placed in a water bath to ensure
complete temperature equilibration. The cells were washed in PBS and either directly fixed or incubated
at 37 C for another 20 min. Afterwards, the cells were immunostained using anti H3N2 and NP antibod-
ies. At zero minutes (A) almost no NP signal was visible while the H3N2 antibody detects bound viruses
on the cell surface. At 20 min (B) free NP was detected in the cytosol, indicating successful fusion and
uncoating. The by-pass leads to successful infection, which was visualized 5 h post-infection (C). The
nuclear NP signal per cell after 5h was quantified using ImageJ based image analysis (D). Scale bar 1 μm
(A, B) 10 μm (C).
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endosomal pH in the absence of viruses was further determined in a whole-cell configuration
where FITC and Rhodamine signals were quantified by flow cytometry (D). The acidification
kinetics are very similar to the single endosome measurements without a co-internalized virus
(Fig. 3.26 B). This indicates that dextran is mainly sorted into the lysosomal pathway (Baravalle
et al., 2005) and thus can be used in comparison with virus-loaded endosome acidification
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Figure 3.25: pH dependence of fusion and HA conformational change of influenza A/X-31. R18-
labeled viruses were incubated with RBC ghosts for 20 min at RT. Virus-ghost suspension was transferred
into 2 ml fusion buffer. The pH was lowered using 0.2 M citric acid and R18 de-quenching kinetics were
recorded over 9 min. Fluorescence de-quenching (FDQ) was calculated according to Eq. 2.1 and plotted
against the pH (A). This plot shows that the fusion starts around pH 6 and reaches a maximum at pH
5.4. Unlabeled virus was mixed with fusion buffer and 3 µM bisANS. The pH was adjusted as described
above and the bisANS signal was followed over 5 min. The final bisANS value was plotted against the
pH (B). As a control, the virus was inactivated by pre-incubation at pH 5 for 10 min, re-neutralized and
used for bisANS binding.
3.7.5 Influenza A/X-31 virus must travel trough early and late endosomes to
ensure successful infection.
Infection was strongly reduced after acid by-pass (see Fig. 3.24), suggesting at least two possible
scenarios. First, a premature release of vRNPs in the cell periphery would increase the risk of
vRNP recognition by cellular factors and trigger the cellular pathogen response. Second, direct
fusion with the plasma membrane circumvents early endosomal residence. This would include a
certain time at a subacidic pH before reaching more acidic late endosomal compartments. Such
a hypothesis was already proposed in 1992 by Helenius (Helenius, 1992b) and suggested that
the virus interior gets acidified at subacidic pH trough the envelope bound proton channel M2
before HA triggers virus-endosome fusion at more acidic pH. A process that would be neces-
sary for virus uncoating. A set of by-pass experiments, where an early endosomal residence was
simulated by a pre-incubation step was used to test this hypothesis.
To evaluate the influence of the proton channel M2, the used virus must be sensitive to the M2
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Figure 3.26: Kinetics of the intra-endosomal pH in the presence and absence of an influenza A/X-
31 virus. MDCK cells were incubated with 10 mg/ml FITC-Dextran and DiD labeled influenza A/X-31
viruses for 5 min at 37 C, immediately washed and analyzed by confocal microscopy (A). If no virus
was present the cells were labeled with FITC/Rho dextran. Ratio imaging of the pH sensitive FITC with
a pH insensitive dye (DiD or Rhodamine) allows determination of the endosomal pH (B). At each time
point, stacked images were obtained to allow tracking of individual endosomes. The presence of the virus
led to a delayed acidification of the endosomal lumen, marked by a slower quenching of the pH sensitive
probe (B, C). The intra-endosomal pH was further determined in a whole-cell configuration where both
signals were quantified by flow cytometry (D). Scale bar 1 μm. Error bars in C correspond to SEM of 10
endosomes form three independent experiments. Error bars in D correspond to SEM of three independent
experiments.
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channel inhibitor amantadine. Since it was reported earlier (Scholtissek and Faulkner, 1979) that
theM2 channel of A/X-31 is resistant to amantadine, a more recent strain influenza A/Panama/99
(H3N2) was tested. MDCK cells were infected with influenza A/X-31 and A/Panama/99 viruses
in the presence of 10 μM amantadine, fixed and immunostained against the viral NP 5 h post-
infection. Figure 3.27 shows that X-31 is resistant to the drug, leaving 90 % cells with a strong
NP signal. In contrast, A/Panama was fully sensitive. Here amantadine completely blocked the
infection in treated cells. Thus, influenza A/Panama/99 was used for all further by-pass experi-
ments.
In a set of by-pass experiments influenza A/Panama was incubated at pH 7, pH 6 or pH 6 with 10
μM amantadine for 30 min at 37 C. The virus was re-neutralized by addition of 0.2 M NaOH,
chilled on ice and bound to MDCK cells for 10 min on ice. Fusion with the plasma membrane
was triggered as described above and the cells were incubated for 30 min, fixed and immunos-
tained against the viral M1 and NP. Figure 3.28 shows summed image stacks representing the
whole cell. If the virus was not pre-incubated and after pH 7 treatment, M1 and NP mostly
co-localize in clusters in the cytosol.
After pre-incubation at pH 6, the number of aggregates decreased and both signals appear to
be more diffuse within the cytoplasm. The presence of amantadine during the pre-incubation
reversed the effect and the two proteins mostly appeared in clusters. The cytosolic M1 signal
was quantified using ImageJ (Fig. 3.29). A region of interest (ROI) was defined in the cytoplasm
of different cells (excluding clusters) and the M1 signal was quantified. Figure 3.29 A shows an
example of a pixel intensity distribution of cells after the indicated treatment. The histogram in
B summarizes the mean values. After pre-treatment at pH 6 the cytosolic M1 signal increased
by 32 %. The presence of 10 μM amantadine led only to an increase of 16 %.
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Figure 3.27: Infection by influenza A/Panama but not A/X-31 is sensitive to amantadine. MDCK
cells were infected with influenza A/X-31 and A/Panama viruses at a MOI of 10-20 in the presence and
absence of the M2 inhibitor amantadine. Infection by X-31 is resistant to 10 μM of the drug leaving
90 % cells infected. In contrast, A/Panama was fully sensitive and here amantadine completely blocked
the infection in treated cells. Scale bar 20 μm.
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Figure 3.28: Pre-incubation at subacidic pH and an active M2 channel allow dissociation of M1 and
vRNPs after acid by-pass of influenza A/Panama/99 with MDCK cells. MDCK cells were incubated
with influenza A/Panama/99 viruses. The cells were either not pre-incubated (A), pre-incubated at pH 7
(B), pH 6 (C) or pH 6 with 10 μM amantadine (D). After pre-incubation, fusion was induced by addition
of cell fusion buffer for 5 min at 37 C. The cells were washed and further incubating for 30 min at
37 C and subsequently immunostained for M1 and NP. Summed image stacks through the whole cell
are shown. Without pre-incubation and after pre-incubation at pH 7, both NP and M1 were found to
co-localize. After pre-incubation at pH 6.0, the amount of aggregates decreased. M1 and NP were found
more homogeneously distributed in the cells cytoplasm. This effect was reduced by the presence of
amantadine. Scale bar 5 μm.
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Figure 3.29: Quantification of the cytosolic M1 signal. A region of interest (ROI) was drawn in the
cytoplasm of different cells and the M1 signal was quantified. Figure 3.29 A shows an example of a pixel
intensity distribution of one cell after each treatment. The histogram in B summarizes mean values of
20-40 cells for each treatment. After pre-treatment at pH 6, the cytosolic M1 signal increased by 32 %.
The presence of 10 μM amantadine led only to an increase of 16 %. Error bars correspond to SEM from
20 - 40 cells from two independent experiments.
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4 Discussion
Influenza virus infection starts with binding of the spike protein HA to receptors on the host
cell surface. This fundamental step in virus replication was characterized in the first part of
this study on living cells by means of single virus force spectroscopy. Combining this method
with experiments characterizing the topography and receptor configuration of three different cell
lines, revealed that the unique features of a cell surface, rather than the receptor conformation
itself, significantly influence virus-cell binding.
This information was then employed to design inhibitory nanoparticles that can mimic the cell
surface and hence be used to prevent virus infection already at the stage of cell binding. In the
second part of this study, the influence of two types of nanoparticles on virus activity was studied
and revealed remarkable inhibitory capacity.
The third part of the study concentrates on entry and trafficking of influenza viruses, i.e. pro-
cesses that directly follow virus-cell binding. Two important mechanisms were identified: (1)
Efficient virus uncoating (i.e. vRNP release) depends on subacidic pH values apparent in early
endosomes. (2) The presence of a virus inside an endosome delays acidification of the endo-
somal lumen. Disturbing these two processes by using specific drugs considerably decreased
virus infectivity. Taken together, these findings could provide hints for future targeted antiviral
approaches.
4.1 Single Virus Force Spectroscopy
Compared to optical trapping of single viruses (Fig. 3.1 and Ashkin and Dziedzic (1987)), it
is much more accurate to use a larger sample carrier, which allows precise calibration of the
optical trap and force measurements with single-pN accuracy. Influenza A viruses were bound
to polystyrene microspheres by non-specific adsorption. This is a simple and common sample-
probe attachment method in AFM and OT based force spectroscopy experiments (Rief et al.,
1997; Li and Liu, 2008; Arya et al., 2005). However, the use of spherical beads also has limita-
tions. Particularly, the contact area between bead and cell surface is very large, which decreases
the probability to detect single virus-receptor interactions as observed for example on MDCK
cells. Hence in this thesis, a low virus concentration per bead was used and permitted measure-
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ments of single virus-receptor interactions.
Meanwhile, more specific and stable attachment protocols have been developed by other groups
(Ebner et al., 2009), and thus, an AFM-based approach was utilized as an additional method.
In the present study, influenza virions were covalently attached to the AFM tip by using a bi-
functional crosslinker (Rankl et al., 2008). Both methods, AFM and OT, revealed unbinding
forces between 7 and 25 pN in the investigated loading rate regime (Fig. 3.2 and 3.3). These
forces are much lower than the adhesive forces between polystyrene and proteins (Sagvolden
et al., 1999), ensuring stable attachment of viruses to the bead surface during the force measure-
ments. The combination of two methods demonstrates the reliability of the new optical tweezers
approach by confirming the measurements by AFM, which was successfully used before to mea-
sure cell adhesion forces of human rhinovirus (HRV) and HIV (Rankl et al., 2008; Dobrowsky
et al., 2008).
Dynamic force spectroscopy using varying pulling velocities revealed the characteristics of the
underlying interaction. For CHO cells investigated by OT, the dissociation constant koff 0.12
s-1 corresponds to a bond lifetime of 8.3 sec without applied force (Fig. 3.2). A broad dis-
tribution of unbinding forces was observed, which led to an increased variability of the values
for koff and xu. This correlates with results from in silico simulations (molecular dynamics) of
the same interaction (Sieben et al., 2012)1. Molecular dynamics (MD) calculate time-dependent
interactions between all atoms within a given system. Force-probe molecular dynamics simu-
lations (FPMD) extend this method by introducing a moving harmonic potential as a “virtual
spring” acting on the ligand thereby pulling it away from the protein (Grubmüller et al., 1996).
Using the crystal structure of HA bound to its receptor (Eisen et al., 1997), force simulations re-
vealed a high variety of unbinding pathways (Sieben et al., 2012). The interaction was shown to
be very dynamic including spontaneous release and rebinding of the receptor to HA. Zipper-like
and all-or-none unbinding events were observed and had a strong impact on the measured force
resulting in high variability as it was observed in this study using experimental techniques.
The obtained values describe a notably weak interaction compared to other lectin-carbohydrate
bonds (reviewed in Helenius et al. (2008)) like Concavalin A (Chen and Moy, 2000) or Helix
Pomatia Lectin (Grandbois et al., 2000) with sialic acid. For comparison, other receptor-ligand
interactions studied by AFM- and OT- based force spectroscopy are listed in Table 4.1. Com-
pared to surface plasmon resonance (SPR) measurements of the interaction between HA and
Fetuin (Takemoto et al., 1996a), a highly glycosylated blood plasma protein, dissociation rates
of about 100 times higher were observed. Since SPR experiments are often complicated by high
re-binding rates, the detected dissociation rates can be drastically decreased. This dynamic is
1 Force simulations using single HA trimers bound to sialic acid have been done in collaboration with Dr. Christian
Kappel and Prof. Helmut Grubmüller from the Max-Planck-Institute for Biophysical Chemistry in Göttingen.
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apparent in the case of multivalent interactions and show the advantage of this interaction type.
Such differences between molecular and cellular dissociation were observed before for HRV and
HIV cell adhesion (Rankl et al., 2008; Dobrowsky et al., 2008) and underline the suitability of
SVFS to investigate binding between live cells and intact virions.
AFM measurements presented here suggest stronger interaction between X-31 virus and CHO
cells ( -2,3-linked SA), compared to MDCK and A549 ( -2,3 and 2,6-linked SA). This con-
tradicts earlier studies showing specificity of X-31 HA to human type receptors (Sauter et al.,
1989; Rogers et al., 1983). Further, the amino acid composition of the receptor binding site in
X-31 HA also indicates specificity for the human type receptor. On the other hand, the receptor
binding site of influenza A/WSN HA points to a rather dual specificity (Gambaryan et al., 1999),
which would explain the very similar bond lifetimes found in AFM pulling experiments using
influenza A/WSN with CHO and A549 cells (also see below 4.3.2).
Interestingly, at least for influenza A/X-31 neither the amino acid composition of HA nor recep-
tor binding studies with purified ligands (Sauter et al., 1989) correlate with the binding prefer-
ence obtained from SVFS measurements performed in this study. This observation suggests that
the unique environment of the receptor on the cell surface strongly affects virus-cell binding.
It further indicates that virus specificity is very complex and that the observed properties of a
certain virus or HA strongly depend on the experimental approach as well as on the level on
which it is investigated. This concept and accompanying parameters will be discussed below.
4.2 Reviewing results from SVFS regarding the cell surface
4.2.1 Receptor composition of the cell surface
The receptor composition of the used cell lines was studied utilizing the well characterized flu-
orescent lectins MAA and SNA. This approach is commonly applied to address receptor com-
position in primary lung sections (Matrosovich et al., 2004a) or in cell culture (Ito et al., 1997).
MAA was reported to be specific for -2,3- (Wang and Cummings, 1988) and SNA for -2,6-
linked sialic acids (Shibuya et al., 1987). However, in particular MAA has certain drawbacks
that have to be considered. The protein exists in two isoforms (MAA 1 and 2) that are selective
for the adjacent sugars. MAA1 binds Sia -2,3Gal 2,3GlcNAc/Glc and MAA2 preferentially
binds Sia -2,3Gal 1,3 (Sia -2,6)GalNAc (Nicholls et al., 2008). Both isoforms recognize -
2,3-linked SA but, depending on the isoform that was used in the experiment, the signal provides
a measure for the adjacent sugars, which could bias the experimental results. SNA has three iso-
forms, but here only SNA-1 very specifically recognizes -2,6-linked SA (Mach et al., 1991).
Another problem that could arise is likely caused by the supplier-dependent fluorescent labeling
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Table 4.1: Receptor-ligand interactions studied by AFM- and OT- based force spectroscopy
interaction koff energy method reference
(s-1) (kBT)
gp120 - CD4 (HIV) 4.1 20.9 AFM Chang et al. (2005)
BabA - Lewis b
(Helicobacter)
0.015 26.5 OT Björnham et al. (2009a)
Galabiose - PapG
(E.coli)
2.6*10-3 28.3 OT Björnham et al. (2009b)
HRV2 - LDLR
(Rhinovirus)
5*10-7 36.8 AFM Rankl et al. (2008)
sLex - selectin
(Leukocyte)
41
0.3
18.6
23.5
AFM Zhang et al. (2004)
Steptavidin - biotin 1.67*10-5
2.09*10-5
33.4
31.1
AFM Yuan et al. (2000)
Digoxigenin -
anti-digoxigenin
0.015
4.6
26.5
20.8
AFM Neuert et al. (2006)
HA - SA
(X-31, CHO cells)
0.12
0.18
24.5
24
OT
AFM
present study
of the lectin. As a consequence, the lectins from different suppliers show altered binding pat-
terns when applied to the same sample (Nicholls et al., 2007). To circumvent the first problem,
a mixture of both MAA isoforms sold by EY laboratories was used in this thesis.
The observed binding was generally very weak on all probed cell lines, a problem that did not
occur for SNA (Fig. 3.7). It was shown before that MDCK (Ito et al., 1997) and A549 cells (Guo
et al., 2009) possess both types of SA linkages and these findings were confirmed in this study
(Fig. 3.7). However, the detected amount of -2,3-linked SA may vary due to the problems
discussed above and thus fluorescent lectins, in particular MAA, can hardly be used to calculate
relative SA abundances. Its correct to state that both SA-linkages are present, but to conclude
that one or the other may be more abundant, is already critical. For CHO cells, the situation is
more clear since those do not express a sialyltransferase specific for -2,6-linked SA and present
only -2,3-linked SA (Xu et al., 2011). Hence, CHO cells are a good model system to study
virus binding to -2,3-linked SA. MDCK and A549 cells present both linkage types and data
presented here indicate that the more abundant linkage is -2,6 (Fig. 3.7). However, a precise
quantitative measure of the cell glycan structure can only be obtained using mass spectrometry
as demonstrated by North et al. (2010).
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4.2.2 Cell surface topography
From section 3.1, it was surmised that the virus-cell interaction mediated by SA-HA binding is
strongly influenced by the presentation of SA on the host cell plasma membrane. In section 3.4,
the cell surface topography was studied utilizing scanning electron microscopy. The cell surface
topography is strongly cell line dependent and is further influenced by the state of cell growth.
In addition, the surface topography depends on the position of the cell within the colony. This
phenomenon was described as cell-to-cell variability and might further influence virus infection
(Snijder and Pelkmans, 2011; Snijder et al., 2009). In the present study, the cells were found to
show a variety of cellular protrusions, presumably microvilli, which can dramatically increase
the cell surface. This is in particular important for epithelial cells due to their polarized organi-
zation and transport function (Rodriguez-Boulan et al., 2005). While the distance between the
microvilli was similar, the length was dependent on the cell line. The protrusions of A549 and
CHO cells were rather long, while MDCK cells featured shorter microvilli (Fig. 3.9).
During initial binding, the virus may either attach to one or more microvilli or to rather smooth
parts of the cell surface between them. Considering the high density of microvilli in a confluent
cell culture (Fig. 3.10), it is more likely for the virus to bind a microvillus than directly on
the smooth cell surface. Indeed, it was observed that influenza A viruses primarily associates
with microvilli on MDCK cells (Matlin et al., 1981). This was also shown for semliki forest
virus (SFV) on baby hamster kidney cells (Helenius et al., 1980). Microvilli are actin-stabilized
and have a diameter of about 100 nm, which precludes direct virus uptake into the microvillus
(Lodish et al., 2007). Thus, the virus needs to move towards the base of the microvillus to en-
ter the cell. This mechanism was described for murine leukemia virus (MLV) (Lehmann et al.,
2005) and was recently revised showing that viruses can actually move between cells exploiting
cellular protrusions (Sherer et al., 2007).
In SVFS experiments, the cells were used at both low (OT) and higher confluency (AFM). At
least for CHO cells, results obtained at both confluency levels can be compared and show that
X-31 binds better to low confluent cells (Fig. 3.2 and Table 3.1 ). However, in particular for
CHO cells, the microvilli presentation did not change significantly during cell growth in culture
(Fig. 3.9 and 3.10) indicating that the surface topography did not account for the different bond
lifetimes.
Nevertheless, the cell surface topography indeed strongly varies between the cell lines, and fur-
thermore, the parameter of the pulling angle has to be considered in SVFS. In OT experiments,
the bead approaches the cell from the side, while AFM cantilevers always operate in vertical
directions. It was shown before that the angle at which a single bond is pulled influences the re-
sulting unbinding force (Ke et al., 2007). Considering the dynamic and highly structured surface
of a cell, no information can be obtained regarding the pulling geometry during SVFS exper-
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iments. A variable pulling angle influences the unbinding behavior and could lead to higher
variation of the resulting forces as observed by SVFS (see 3.1). One way to circumvent this in
force spectroscopy is to use a flexible linker between surface and receptor as well as between
cantilever and ligand. This could be accomplished by using polyethylene glycol (PEG) or DNA
(Neuert et al., 2006; Cecconi et al., 2008), but is not applicable for receptors on cells due to
their natural presentation on the cell surface. However, during the AFM experiments, the virus
was attached to the cantilever using a PEG crosslinker, thereby providing a certain amount of
flexibility.
4.2.3 Interaction complexity affects receptor speci city.
SVFS investigates binding forces of single or a few receptor-ligand complexes. A fluorescence-
based binding assay was used to compare the results from SVFS with whole-cell virus bind-
ing (i.e. many simultaneous interactions). R18-labeled viruses were incubated with a defined
number of cells from each cell line and the R18 signal per cell was quantified using flow cy-
tometry. Considering multivalent binding, one would expect that small differences measured by
SVFS translate into more pronounced differences when looking at multiple interactions on the
whole-cell level. Influenza A/X-31 bound better to CHO than to MDCK and A549 (Fig. 3.4)
as expected from SVFS. Interestingly, A/WSN bound better to CHO than to A549 cells, which
contradicts the AFM results. This supports the earlier conclusion that receptor specificity and
cell specificity are not necessarily connected. Receptor specificity is presumably mainly deter-
mined by HA, i.e. the structure of the receptor binding site (Imai and Kawaoka, 2012). How the
cellular specificity is established, remains to be investigated.
In summary, these results point to multiple levels of complexity that have to be considered for
understanding virus-cell binding. The proposed levels of complexity as well as their major de-
termining factors are summarized in Fig. 4.1. Hence, the results obtained on virus specificity
critically depend on the applied technique, since each method targets virus binding on a different
complexity level. Technical aspects and the role of the mentioned dual receptor binding behavior
are discussed in the next section.
4.3 Dual receptor binding behavior
4.3.1 Technical considerations
Among the first who studied the receptor specificity of HA, Rogers et al. (Rogers et al., 1983)
used sialidase treated (asialo) erythrocytes which where specifically re-sialylated with either
-2,3- or -2,6-linked SA, an elegant approach that is still used in current publications (Glaser
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complexity level method reference
hemagglutination
flow cytometry
sialylated RBCs
AFM, OT
SPR, NMR,
glycan arrays
A
B
C de Vries, 2010
Blixt, 2004
Takemoto, 1996a
Sauter, 1992
Sieben, 2012
Rankl, 2008
Dobrowski, 2008
Sieben, 2012
Glaser, 2005
Rogers, 1993
Figure 4.1: Virus receptor specificity can be measured on different complexity levels using special-
ized methods. Virus specificity can be measured on the whole-cell level (A) as well as on the single virus
level (B). These two techniques have the advantage that viruses and cells are intact and thus represent the
natural situation. Receptor specificity can further be analyzed utilizing purified binding partners, such as
SA-coupled ligands or HA (C). This approach allows precise control over the studied ligands, but ligand
density and orientation can barely be adjusted. AFM, atomic force microscopy; OT, optical tweezers;
SPR, surface plasmon resonance; NMR, nuclear magnetic resonance
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et al., 2005; Tumpey et al., 2007). However, among other methods, solid-phase binding assays or
glycan arrays represent a widely used convenient way to analyze HA-receptor interactions (Blixt
et al., 2004). The desired ligand is coupled to a flat surface and can either be probed with intact
viruses (Imai et al., 2012) or purified HA (Stevens et al., 2006; de Vries et al., 2010), which
is then detected using antibody binding. Other studies used NMR (McCullough et al., 2012;
Sauter et al., 1989) or SPR (Takemoto et al., 1996b) to measure receptor binding (Fig. 4.1).
These studies used purified SA receptors as binding partners for HA and certainly provide very
accurate binding profiles and affinities. However, already on this level the techniques (including
sample preparation) are not directly comparable. The ligand density, which likely affects binding
(see 4.4 below) is not easily controllable. SPR is known to often underestimate dissociation due
to high re-association rates. A problem that becomes apparent when using multivalent ligands
(e.g. viruses). This might also be the case for force spectroscopy studies. Here the ligand
is immobilized on a force transducer leading to an almost two-dimensional dissociation and
reduced ligand entropy. Indeed, it is important to consider the described factors, but among the
current techniques, SVFS is the only tool to measure virus-cell adhesion in a set-up that closely
mimics the natural situation.
4.3.2 Dual receptor speci city
The above mentioned studies often report dual receptor binding, meaning HA binds both, avian
and human receptors. However, HA often shows a preference for one of the two types and hence
receptor specificity is to be understood as preferential binding. HA from influenza A/X-31
was shown to preferentially bind -2,6-linked SA (Takemoto et al., 1996b; Sauter et al., 1989;
Rogers et al., 1983). The identified critical amino acids in H3 HA at position 226 (leucine)
and 228 (serine) further indicate binding of X-31 HA to human type receptors. For H1 HA, the
critical amino acids were identified at position 190 and 225 (Gambaryan et al., 1999). With glu-
tamic acid at position 190 and aspartic acid at position 225 the HA of A/WSN shows similarities
to both the avian and human consensus sequence, but preferentially binds -2,6 sialylated red
blood cells (Leung et al., 2012).
As mentioned above, it is difficult to make predictions about receptor binding based on the
amino acid composition of the receptor binding site. As an example, H1 from influenza A/Cal/09
(H1N1), an isolate from the recent pandemic, exhibits aspartic acid at positions 190 as well as
225 and thus should preferentially bind human type receptors. In contrast, the virus shows pro-
nounced dual binding to both receptors, a property that is opposed to seasonal H1 viruses and
might be linked to the pandemic character of A/Cal/09 (Childs et al., 2009). Indeed, H3 from
A/X-31, which originates from the pandemic virus A/Aichi/2/68 (H3N2) as well shows dual
binding behavior (Childs et al., 2009). This suggests that also on this level, many other factors
90
4.3 Dual receptor binding behavior
might play a role in determining the receptor specificity.
Regarding the virus, other critical amino acids where reported for various HAs that favour bind-
ing to a variety of different complex glycans (Stevens et al., 2006). This means that when
studying cellular specificity, it is important to consider the complex glycans behind the terminal
SA linkage. Another important factor is the glycosylation state of the virus itself. HA being
a transmembrane protein, follows the secretory pathway and thus underlies secondary protein
modifications. It is glycosylated inside the ER and Golgi apparatus (Keil et al., 1985) and the
structure of the glycans critically depends on the infected host cell (see 1.4.1). The glycosyla-
tion state of HA was shown to alter the receptor specificity (de Vries et al., 2010). Apart from
carbohydrate modifications, further host-cell factors where shown to be involved in virus-cell
binding. Recently, blocking of fibronectin was shown to interfere with influenza A virus entry
(Leung et al., 2012). Remarkably, only -2,6 specific viruses were affected. The study by Lon-
drigan et al. showed that other proteinaceous receptors including DC-SIGN or L-SIGN can act
as SA-independent attachment factors (Londrigan et al., 2011).
To conclude, Stray et al. provided evidence for influenza virus infection in the absence of sialic
acid, suggesting other possible attachment factors (Stray et al., 2000). Hence, virus-cell binding
is a very complex process that goes beyond HA-SA interaction. As stated above, the present
study further hypothesizes different levels of complexity that influence virus binding and must
be considered.
4.3.3 Relevance of the HA-SA binding for influenza virus infection
Several recent studies suggested that receptor binding might not correlate with infection per se.
The study presented by Chu and Whittaker (Chu and Whittaker, 2004) described an important
role for N-linked glycans in influenza virus infection. The study describes the infection of Lec1
cells, a mutant CHO cell line deficient of the N-acetylglucosaminyltransferase I (GnT1) gene.
It was found that virus invasion is stopped at the point of entry after virus attachment. A more
recent study puts these results in a different light. De Vries et al. (de Vries et al., 2012) inves-
tigated the dependence of N-linked glycans using other cells than the Lec1 CHO mutant. They
conclude that N-linked glycans are not essentially required but that other post-attachment factors
are important for virus entry, a hypothesis that was also mentioned by Chu and Whittaker (Chu
and Whittaker, 2004). Indeed, the involvement of multiple entry pathways (Mercer et al., 2010),
the de novo induction of clathrin-mediated endocytosis (Rust et al., 2004) and the use of specific
adaptor proteins such as Epsin 1 (Chen and Zhuang, 2008) suggests that more specific signals
than the initial HA-SA contact are necessary to trigger internalization and promote infection.
These signals might be responsible for the missing link between binding and infection that was
characterized in the present study. SFVS experiments of influenza A/X-31 nicely correlate with
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whole cell binding studies, indicating better binding to CHO and comparable binding to MDCK
and A549 cells. This binding behavior is not translated into better infection efficiency. MDCK
cells showed higher NP production when infected separately and in a competition assay grow-
ing side-by-side with CHO cells. These results suggest the existence of post-attachment factors
necessary for efficient infection in MDCK cells, a finding that is supported by the study of
Nunes-Correira et al. (Nunes-Correia et al., 1999) presenting a kinetic model for virus binding
to and endocytosis in MDCK cells. The study points to two kinds of binding sites: (1) low-
affinity receptors responsible for binding and (2) high-affinity receptors responsible for uptake.
It is also possible that the observed differences in infectivity are related to the cellular pathogen
defense response. A quantitative proteomic study comparing A549 with MDCK cells detected
a changed abundance of interferon induced Mx proteins (Vester et al., 2009). Mx GTPases rep-
resent a family of antiviral proteins that interfere with the viral polymerase complex (Ehrhardt
et al., 2010). The innate immunity might also be directly connected to receptor binding. Interest-
ingly, in a recently presented hypothesis, virus binding to either human or avian type receptors
activates differential immune signaling pathways (Ramos and Fernandez-Sesma, 2012), a fac-
tor that is important considering preferred binding or more dual-binding behavior of influenza
viruses.
4.4 Inhibition of influenza A virus activity using multivalency
As mentioned above, a cell surface without sialic acid does not protect from influenza A virus
infection. However, it is well accepted that SA is the major receptor for HA, a fact that is
known for more than 50 years (Gottschalk, 1959). In addition, it is well known that HA is the
most abundant spike protein. The virus overcomes the problem of weak interaction between HA
and SA by using multiple interactions as studied by SVFS in this study. This generates strong
binding and permits agglutination of red blood cells, a property that was known before SA was
identified as the receptor. For this study, the idea was to mimic this multivalent interaction and
thereby prevent virus-cell binding. This concept was studied before using many different scaf-
folds as described in section 1.3.2. The most potent inhibitors reached effective concentrations
in the pM range (Mammen et al., 1995). These inhibitors were polyacrylamide-based and tested
exclusively in vitro. Other scaffolds such as dendritic polymers (Reuter et al., 1999) or polyami-
doamine (PAMAM) dendrimers were also tested in cell culture or mouse models (Landers et al.,
2002) and reached effective concentrations in the μM range. Important to consider is the cy-
totoxicity, which is high for polyacrylamide and much lower for the later mentioned polymers.
In the present study, spherical polyglycerol (PG) particles were used. Polyglycerols are highly
biocompatible and can be synthesized in different sizes ranging from 1-100 nm (Calderón
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et al., 2010; Sisson et al., 2009; Reichert et al., 2011). According to the results from SVFS that
the SA linkage does not play a primary role in binding, the used particles were functionalized
with only SA.
4.4.1 Inhibition of influenza virus binding
Two different size regimes were tested for their effect of SA surface content (dF, see section
2.1.5). Small PGs with a diameter of about 3 nm and larger PGs of 40 - 80 nm were tested.
The size relation between nanoparticles and virus is summarized in Fig. 4.2. The binding
was tested using a flow cytometric approach, where binding of fluorescently labeled viruses is
measured in terms of signal per cell (Fig. 3.11). Both PG variants show an evident concentration
dependent effect, but with a different progression. For the small PGs, RBC binding was inhibited
in a linear fashion, without an effect of the dF (Fig. 3.11). In contrast, the larger PGs bound
in an exponential manner and showed a strong dF-dependence. This indicates that increase
in size leads to a fundamentally different binding behavior. Due to their size, the small PGs
can presumably only bind 1-3 HA trimers and consequently benefit only minimally from steric
stabilization. The higher local SA concentration still leads to better binding compared to the
monomeric ligand. Likely, these particles merely act as competitive binding inhibitors for SA
on the cell surface. The larger PGs had a pronounced effect at small concentrations which
quickly saturated, without further increase of inhibition. The inhibition curve saturated at 1 mM
SA concentration and inhibited virus-cell binding by 60 % (PG 5, dF = 80%) and 80 % (PG 4,
dF = 12%). The data indicates that binding at this concentration ceased to be affinity dependent.
Otherwise, higher concentrations would lead to better binding and stronger inhibition.
Several conclusions can be made from this behavior. Up to 1 mM SA, both PGs bind viruses,
but PG 4 binds distinctly better and shows about double the inhibition of virus-cell binding. At
the same SA concentration, the effect of the small PGs is less pronounced indicating a steric
contribution for the larger PGs 4-5 (Mammen et al., 1995; Choi et al., 1996). At least two
reasons can account for the difference between PG 4 and 5: (1) The increase of charged SA
side chains also increases repulsion of the particles, which could lead to destabilized binding
(Reuter et al., 1999; Mammen et al., 1995). This may alter hydration and thereby change the
form of the PG away from ideally spherical (Reuter et al., 1999; Mammen et al., 1995; Kiessling
et al., 2000). More flexibility would lead to increased binding as observed for polyacrylamide
polymers (Mammen et al., 1995). (2) Another aspect is the distance and flexibility of each
individual ligand. A fourfold increase of ligand density on a PG of a given size (i.e. similar
contact area between PG and virus) can negatively affect binding due to a higher fraction of
unbound ligands.
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PG 1 - 3
Ø 3-5 nm
(6-36 x SA) 
Au NPs
Ø  2   nm 
    14 nm
(50-3000 x SA)
PG 4 - 5
Ø 50-70 nm
(10⁴-5*10⁴ x SA) 
influenza A virus
Ø ~100 nm
~ 1000 HA
monomers per
virion
Figure 4.2: Size comparison of the used SA-conjugated nanoparticles with an influenza A virus.
4.4.2 Inhibition of influenza virus fusion and infection
Even at high concentrations of inhibitory nanoparticles, some viruses could still bind to the target
cell surface. To test the functionality of HA, its ability to mediate fusion and enable infection was
tested by R18 fluorescence de-quenching and anti-NP immunostaining respectively. Notably,
after virus-cell binding, the RBC ghost-virus suspension was pelleted to separate unbound virus.
That means that only the fusion activity of viruses that were still able to bind was detected. The
overall virus activity then arises from the product of inhibition of binding and fusion.
Both PG variants inhibited fusion more prominently than binding. This is not surprising since
HA-mediated fusion is supposed to be a cooperative process (Bentz, 2000; Markovic et al., 2001;
Floyd et al., 2008) and virus-cell binding can be mediated by as little as one HA. However, the
investigation of HA reconstituted in vesicles suggests that single HA trimers can mediate fusion
as well (Imai et al., 2006). In this scenario, fusion inhibition is expected to be as strong as
binding reduction. Stronger fusion inhibition, as shown in this study, indicates the presence of a
minimal HA aggregate size to initiate fusion, supporting the cooperativity model. Virus binding
to inhibitor nanoparticles blocks a subset of HA trimers that cannot engage in fusion.
Fusion inhibition was less pronounced for the higher dF PG 5. This supports the described
hypothesis of charge repulsion leading to sparser packing of PG on the virus surface. This
would allow some of the HA trimers to form functional complexes that can mediate fusion.
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To successfully infect a cell, the virus needs to enter the host cell, fuse with the endosome and
deliver its genomic material. The PG effect on these first steps of infection until NP production
was tested for one of the small PGs and compared with the larger PG 4. The larger PG 4 inhibited
infection by 80 %, while the smaller PG reduced it by 40 %. The effect was less pronounced than
expected from fusion inhibition. However, it has to be considered that the fusion as observed by
R18 de-quenching is the results of the fusion activity of an ensemble of viruses. In this fusion
assay, 5 % remaining activity still means thousands of viruses. Genome delivery of a few viruses
may suffice to render a cell infected in the immunostaining assay.
4.4.3 Gold nanoparticles as tools for imaging-activity-correlation
To study multivalency, gold nanoparticles have a crucial advantage compared to polyglycerol:
their high contrast in transmission electron microscopy (TEM). The application of SA func-
tionalized gold particles permits a new type of molecular imaging-activity correlation. Gold
particles with a diameter of 2 and 14 nm were first tested for their binding capacity to HA. Gold
nanoparticles quench organic fluorophores in a distance dependent manner by a mechanism that
is not yet fully understood (Schneider et al., 2006; Hazarika et al., 2006). These properties were
used to quench the emission of YFP tagged to HA expressed in CHO cells (Fig. 3.15). This
experiment showed that the particles indeed specifically bind to HA, but that the binding was
very weak as a single washing step almost eliminated the effect. However, binding was veri-
fied by hemagglutination inhibition (HAI), where the particles were found to be still effective
in the low nM range (particle concentration). This corresponds to a SA concentration of 10-
50 µM, a very high value compared to other studies where HAI was achieved with nM or pM
SA concentrations (Spaltenstein and Whitesides, 1991; Mammen et al., 1995). This difference
could be explained by the tight packing of ligands on the particle surface. Unfortunately, the
ligand density could not be controlled and the gold nanoparticles were found to be constantly
fully coated. This reduces flexibility and accessibility of each ligand and results in high negative
surface charge, possibly reducing virus binding.
Inhibition of agglutination was achieved only by using the 14 nm particles, while the smaller 2
nm colloids had no effect (Fig. 3.14). The failure of the 2 nm particles to inhibit hemagglutina-
tion is possibly due to their binding architecture. The diameter of an HA trimer is about 7 nm
and thus the smaller 2 nm particles can not bind to multiple trimers. This binding mode was
verified by TEM, showing clearly that the 2 nm particles can only bind one trimer, while the
larger particles can be connected to approximately 3-5 trimers.
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4.4.4 Relevance and optimization of multivalent inhibitors
Due to the multivalent interaction between virus and cell surface, the virus effectively never
unbinds, even if single HA-SA connections are opened and closed at high frequency. This pro-
posed binding mechanism is based on SVFS and whole-cell measurements performed in this
study. It was the idea to mimic this situation by using nanoparticles exposing multiple copies of
SA on their surface. Via combined competitive binding and steric stabilization of the complex,
viruses can efficiently be trapped before they can engage with cell surface receptors.
Earlier studies often faced high cytotoxicity and were limited to hemagglutination inhibition
(Spaltenstein and Whitesides, 1991; Mammen et al., 1995). In the present study, it was shown
that the used particles are biocompatible and efficiently inhibit infection of MDCK cells. As
described in section 1.4.2, SA is involved in a variety of host interactions. The studied nanopar-
ticles might therefore be used to inhibit other pathogens as well. Targeting Siglecs was shown
before to control B-cell regulation (Courtney et al., 2009), thereby suggesting another possible
application for SA-conjugated PGs. Mouse models could be used to evaluate the effect of PGs
on influenza infection in vivo as demonstrated for PAMAM dendrimers (Landers et al., 2002).
Sulfated PGs were recently shown to inhibit inflammation in vivo (Dernedde et al., 2010).
However, sialic acid is involved in many signaling pathways (as described in 1.4.2) and could
produce unwanted side effects. Recent publications therefore suggested alternatives for SA, pos-
sibly avoiding SA-related side effects. For example, several studies used HA-targeting peptides
that bind efficiently to HA and inhibit infection (Rajik et al., 2009; Nicol et al., 2012; Matsubara
et al., 2010). The use of a more complex sugar such as sialyllactose could increase the affinity
and thus lower the required amount of inhibitor. A disadvantage of this approach would be the
susceptibility against digestion by NA, which would inactivate the inhibitor. However, this links
to another concept which was introduced by Choi et al. (Choi et al., 1996). Here monomeric
NA inhibitors were used to bind NA in addition to HA. This synergistic binding of two ligands
enhanced the steric stabilization of the virus-inhibitor complex.
4.5 Intracellular traf cking of influenza A viruses
4.5.1 Spatio-temporal characterization of intracellular fusion
The initial part of influenza A virus infection was studied to identify and characterize poten-
tial targets for antiviral therapy. Some major steps of cell entry are already well described
(Lakadamyali et al., 2004). It was shown that the virus is internalized predominantly via clathrin-
mediated endocytosis (Rust et al., 2004), but can also infect in the absence of clathrin (Sieczkarski
andWhittaker, 2002b). Moreover, macropinocytosis (de Vries et al., 2011; Rossman et al., 2012)
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and also entry via caveolae (Nunes-Correia et al., 2004) were shown to mediate virus entry into
the host cell.
Live cell imaging in combination with single particle tracking provided important insights into
the dynamics of cell entry and trafficking. It was shown that the virus is rapidly transported
along microtubules while quickly passing Rab5-positive early endosomes (after 5 min) to
co-localize with Rab5 and Rab7 on maturing endosomes (multivesicular bodies), where most of
the fusion events where detected (Lakadamyali et al., 2006). These findings could be confirmed
in this study. The combination of intracellular fusion and co-localization confocal microscopy
shows that viruses quickly progress along the endosomal system and that indeed, the majority
of fusion events happen between 5 and 20 min, which corresponds to localization in maturing
endosomes (see 3.7.1). Although it is technically demanding to study the first 10 min with high
time resolution, it could be shown that intracellular virus fusion started almost immediately and
even occurs in early endosomes (see Fig. 3.20). Early endosomes have a lumenal pH of 6.1
- 6.8 (Huotari and Helenius, 2011), which is higher than the optimal fusion pH of influenza
A/X-31 (Korte et al., 1999). However, virus-ghost fusion showed a clear onset of fusion at a
pH slightly above 6, which would enable fusion with early endosomes (Fig. 3.25). Notably,
the R18 de-quenching assay primarily detects lipid mixing, which is the first step of membrane
fusion (hemifusion, Harrison (2008); Floyd et al. (2008)). The onset of content mixing (i.e. viral
genome release) happens at slightly lower pH values (Chernomordik et al., 1998). The endoso-
mal system is highly dynamic and thus the endosomal pH also underlies some variation. The
low number of fusion events within early endosomes and the low virus-ghost fusion at pH above
6 further suggest that early endosomes are not the preferred localization of fusion for the virus.
Nocodazole treatment was shown to have a strong effect on influenza virus infection. The drug
interferes with microtubule polymerization, which leads to missorting (Lakadamyali et al., 2006)
and inhibits intracellular virus transport (Lakadamyali et al., 2003). After nocodazole treatment,
a random sorting of viruses into different types of early endosomes was observed, some of which
may not progress towards the lysosomal pathway (Lakadamyali et al., 2006). This suggests a
strong effect of nocodazole on virus fusion and infection.
Indeed, it could be shown that the drug strongly inhibits virus infection and this correlates with
reduced fusion kinetics (Fig. 3.23). Since the fusion kinetics represent the sum of many fused
viruses, there are at least two reasons explaining the inhibitory effect on virus fusion: (1) Ei-
ther less viruses undergo fusion or (2) the area of endosomal membrane that is available for the
dilution of viral envelope-bound R18 is smaller. To test these hypotheses, virus fusion events
after nocodazole treatment were quantified. The number of fused viruses was similar in noco-
dazole treated and control cells (Fig. 3.22). In addition, the localization of fusion events was
categorized and scored as either peripheral or perinuclear (PNR). In untreated cells, the majority
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of fusion events were perinuclear as expected from Lakadamyali et al. (2003) and Sakai et al.
(2006). This is in line with the observation that cargo bound for degradation (i.e. taking the
lysosomal route) also travels towards the cell center (Baravalle et al., 2005; Bayer et al., 1998).
Interestingly, this accumulation was lost after nocodazole treatment (Fig. 3.22). Taken together,
this indicates that after nocodazole treatment the number of fusion events is not reduced but the
resulting de-quenching is less pronounced. This could be explained by fusion with early endo-
somes, which are smaller than late endosomes (Rink et al., 2005) and thus only allow reduced
de-quenching, i.e. dilution of the fluorophore R18.
Nocodazole was further shown to increase the pH in transferrin-loaded but not in dextran-loaded
endosomes (Baravalle et al., 2005). In the case of transferrin, the drug prevented only the sec-
ond phase of acidification happening in perinuclear recycling compartments (PNRC), leaving
the first phase of acidification in early endosomes unchanged (Baravalle et al., 2005). After
exiting early endosomes, influenza viruses do not travel towards perinuclear recycling compart-
ments, but rather take the lysosomal route towards late endosomes. This suggests that the pH
encountered by the virus during trafficking should not be affected by nocodazole (Bayer et al.,
1998).
In summary, influenza viruses quickly travel through the endo-/lysosomal system, mostly fuse
in maturing endosomes and reach the perinuclear region after 10 - 20 min. Interference with
the microtubule disrupting drug nocodazole leads to randomly localized but equally numbered
fusion events compared to untreated cells. Fusion kinetics show reduced de-quenching possibly
due to fusion with smaller endosomes that have not yet matured to late endosomes. Nocodazole
treatment further drastically decreases infection, suggesting a correlation of the localization of
fusion with the success of infection. Hence, it is important for the virus to reach the perinuclear
region before the pH decreases below the threshold necessary to trigger fusion.
4.5.2 Influenza virus can delay the endosomal acidi cation to optimize the
localization of fusion and genome release.
Technical considerations
Due to fast endosomal transport, the localization of fusion critically depends on the acidifica-
tion kinetics inside the endosome. To assess the pH on the single endosome level, fluorescent
indicators were co-internalized with labeled viruses and their signal was followed over 30 min.
This type of measurement has some critical aspects. The pH-sensitive spectral properties of the
fluorophore must be calibrated in order to deduce the pH from the fluorescence intensity. To
this end, endosomes were loaded with labeled dextran followed by an incubation step in pH
standard buffers on ice. During this step the pH is equilibrated and ATP is depleted to avoid
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further influence of the proton pumps. The addition of proton ionophores allows equilibration of
all internal compartments. This is a widely used standard procedure to calibrate pH (in)sensitive
fluorophore pairs in cells considering the intracellular pH to be equal to the extracellular stan-
dard medium (Brabec et al., 2005; Bayer et al., 1998; Baravalle et al., 2005).
However, in a live-cell measurement other factors could be involved and change the spectral
properties of the fluorophore. The different amounts of endosomal loading can be deduced from
intensity differences and can be explained by differently sized endosomes. In addition, com-
ponents of the extracellular cell culture medium might also change the endosomal environment
and could lead to changed buffering capacities of the endosome or directly interfere with the
spectral properties of the fluorophore (Han and Burgess, 2010). Due to these problems, instead
of co-internalization, direct coupling of the pH sensor to the virus might reduce the experimental
background (Lakadamyali et al., 2006, 2003). Other fluorescent indicators like the GFP variants
E2 GFP (Bizzarri et al., 2006) or pHRed (Tantama et al., 2011) allow to asses the pH from ra-
tiometric or fluorescence lifetime imaging and thus reduce the experimental system to only one
fluorophore.
Lastly, the size of an endosome itself underlies some variability. For example, small endosomes
(d = 200nm) have only a volume of V = 4.2 10 18l. Consequently, at pH 6, this corresponds
to 2.5 protons and to 0.5 protons at pH 7 respectively. As described by Sakai et al. (Sakai et al.,
2006) the endosomal pH must be considered very carefully and is subjected to the described
variations which were also observed in this study and resulted in significant scattering of the
data (see Fig. 3.26). Considering the pH as an ensemble property, the application of this pa-
rameter to the endosomal situation remains questionable. Thus, it might be beneficial to assess
only qualitative differences rather than pH values as done by Murakami et al. (Murakami et al.,
2012). However, in the present study pH values were calculated being aware of the problems
outlined above.
Influenza virus delays the endosomal acidi cation. Implications for ef cient infection.
By determining pH values of single endosomes with and without a loaded virus, it was possible
to show for the first time that the presence of an influenza virus has an effect on the acidification
of the surrounding endosome. During the first 15 minutes post infection, the virus leads to a
retarded pH decrease compared to the uninfected control (Fig. 3.26). To correlate these results
with intracellular fusion and endosomal localization, Fig. 4.3 shows a summary of the early
events during influenza A virus infection characterized in this study. Measurements of fusion
and pH are accompanied by accumulation kinetics of viral NP inside the nucleus 2. It should be
2 These data were produced during a practical course under my guidance, but represent only one measurement and
where thus not presented in the results section.
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noted that at this early stage of infection ( 30 min) the detected NP corresponds to NP brought
inside the cell by the infecting virus and does not include newly produced protein.
The graph shows that fusion starts early and overlaps with early endosomal localization. Most
fusion events occur between 5 and 20 min, localized in maturing endosomes. In this period,
the presence of the virus has the strongest effect on the endosomal pH compared to the control.
It is followed by NP accumulation inside the nucleus after 10 - 15 min. During this time, the
endosomal pH drops from 7 to 6, which according to Fig. 3.25 would only allow very limited
fusion. It must thus be concluded that the actual endosomal pH is lower but can not be detected
with high accuracy due to technical reasons mentioned before.
One hypothesis that emerges from these results is that the virus buffers the endosomal pH by
proton binding to viral components. Regarding the size of an endosome, an internalized virus
represents a remarkably high protein concentration ( 100 mg/ml for a 200 nm endosome). Not
only the dense layer of spike proteins but rather internal components such as M1, NP and RNA
provide a high buffering capacity (David Holcman, Thibault Lagache personal communication).
This is promoted by the simultaneous opening of the M2 proton channel (Leiding et al., 2010),
allowing protons to enter the virus interior and bind to a large pool of RNA and proteins. This
strategy enables the virus to reach locations close to the nucleus before the pH for efficient fu-
sion is reached and, hence, before fusion is triggered. Accordingly, disruption of microtubule
associated transport and by-pass experiments lead to strongly reduced infection.
About the reason for the observed reduction of infection in the presence of nocodazole can only
be speculated. If fusion occurs more distant to the nucleus, the probability that the viral genome
becomes a target of cellular defense mechanisms before reaching the nucleus may increase. An
underlying mechanism could be the recognition of vRNA by the RNA helicase RIG-I, which
leads to activation of transcription factors IRF3 and/or IRF7 and subsequent induction of inter-
feron / genes (Ludwig et al., 2006). Other viral proteins including NP, M1 and HAwithin the
cytoplasm activate nuclear factor B (NF- B) via activation of I B kinase 2 (IKK2) (Ludwig
et al., 2006). This as well leads to interferon induction and apoptosis. Thus, mechanisms of the
cellular innate immune response suggest that premature virus fusion negatively influences virus
infection. On the other hand, if viruses fail to fuse, they reach lysosomal compartments and get
degraded. In this case, endosomal Toll-Like receptors TLR3 and 7 recognize vRNA and as well
induce interferon response (Diebold et al., 2004).
However, these hypotheses remain to be verified experimentally, but some recent studies support
the conclusion that time and localization of fusion are important determinants for virus infec-
tion. The stability of HA controls the pH threshold of the conformational change (Rachakonda
et al., 2007) and thereby could affect intracellular fusion. This suggest a correlation between
HA stability and infectivity as revealed by some recent studies (Murakami et al., 2012; Imai
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et al., 2012; DuBois et al., 2011). Hence, HA stability must be optimized to allow extracellular
stability of the virus as well as to control the intracellular time and localization of fusion and
genome release.
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nuclear NP
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Figure 4.3: Summary of the early events during influenza A virus infection characterized in this
study. The plot correlates the kinetics of pH acidification with those of fusion and nuclear NP accumula-
tion. The graph shows that fusion starts early and overlaps with EE localization. Most fusion events occur
between 5 and 20 min, localized in ME. In this period, the presence of the virus has the strongest effect
on the endosomal pH compared to the control. It is followed by NP accumulation inside the nucleus after
10 - 15 min. The localization of the virus within the endo-/lysosomal system is shown above the graph.
EE, early endosome; ME, maturing endosome; LE, late endosome; LY, lysosome; NP, nucleo protein
4.5.3 Influenza A/X-31 virus must travel through early and late endosomes to
ensure successful infection.
Uncoating of influenza virus includes dissociation of the M1 protein layer, fusion of viral with
endosomal membrane and release of the viral vRNPs into the cytoplasm. As mentioned above,
the onset of fusion is preceded by opening of the viral proton channel M2 (Leiding et al., 2010).
A possible uncoating mechanism was already proposed in 1992 (Helenius, 1992a) following the
identification of M2 as a channel for monovalent cations (Pinto et al., 1992). The inhibitory
activity of amantadine was known before and the drug was shown to inhibit an early step of
influenza virus infection (Skehel et al., 1978). Ever since it has been speculated about the un-
coating process and it was assumed that acidification of the viral lumen by M2 proton transport
supports virus uncoating possibly by subsequent dissociation of the M1 layer (Webster et al.,
1992; Whittaker, 2001). It was shown that M1 separates from vRNPs after release into the
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cytoplasm and that vRNPs travel into the nucleus without M1 (Martin and Helenius, 1991a).
Overexpression of M1 causes binding of M1 to vRNPs, inhibiting their nuclear transport. This
can be reversed by acidification of the cytoplasm and results in rescued nuclear targeting of
vRNPs (Bui et al., 1996). These results together with the reported pH-dependent dissociation
of M1 (Zhang et al., 2012) resulted in the current model of influenza uncoating. However, the
sequence of the uncoating events which presumably depends on virus residence in early and late
endosomes (Sieczkarski and Whittaker, 2003) has not been uncovered.
The ability of the virus to delay the endosomal pH decrease raised the question whether the
subacidic pH present in early endosomes is also necessary for virus uncoating. In order to study
the importance of early endosomal residence, by-pass experiments were conducted in which
the virus was pre-incubated at a defined pH before fusion was triggered with low pH buffer.
Pre-incubation at neutral pH simulates direct late endosomal localization without transit through
early endosomes. Here M1 co-localized in clusters with NP, which indicates that both proteins
do not separate after release into the cytoplasm. A similar result was found in electron mi-
croscopy studies (Fontana et al., 2012; Calder et al., 2010). While at neutral pH, the M1 layer
and vRNPs can be detected inside the virus, these structures are replaced by a coagulate after
short incubation at pH 4.9. The coagulate is not present at pH 7 and it does not co-localize in
virions with M1 and vRNPs, suggesting that the coagulate is made of vRNP and M1 (Fontana
et al., 2012). In these clusters vRNPs may no longer be accessible for virus reproduction. This
could be an additional explanation for the loss of infectivity after acid by-pass, described in 3.7.3
and discussed above. However, the observation was different when the virus was pre-incubated
at pH 6 before fusion was triggered by low-pH treatment. In this case, the cytosolic M1 and
NP signals were higher and less M1-NP clusters were observed (Fig. 3.28). This indicates that
although low pH leads to dissociation of M1 and NP as shown by Zhirnov (1992) and Bui et al.
(1996) subacidic pH seems to be more favorable for this process and thus renders early endo-
somes residence essential for efficient virus infection. Quantification of cytosolic M1 showed
that the signal was indeed higher when the virus was pre-treated with subacidic pH buffer simu-
lating early endosomes (Fig. 3.29). Accordingly, when the acidification of the virus lumen was
blocked by amantadine the effect was reduced and acid by-pass resulted in M1/NP clusters (Fig.
3.28).
4.5.4 Model for the stepwise uncoating of influenza A virus
From these results, a sequential model for the uncoating of influenza virus can be concluded.
The model is summarized in Fig. 4.4. Following entry, the virus quickly reaches early endo-
somes with subacidic pH, which leads to opening of M2 (Leiding et al., 2010) and acidification
of the viral lumen. Viral components inside the virus such as vRNA and proteins bind a signif-
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icant amount of protons, leading to a delayed endosomal acidification. M1-M1 and M1-vRNP
contacts are loosened during this step (Zhirnov, 1992; Ye et al., 1999). The dissociation and
eventual collapse of M1 must be controlled. The virus has to make sure that vRNPs detach from
M1, before both coagulate at acidic pH (Li and Sieben et al., submitted). This might be a slow
process and benefit from the delayed endosomal acidification. Another positive consequence
of this delay is that viruses are further transported towards the nucleus before fusion is trig-
gered, thereby decreasing the distance for the vRNPs to travel. Endosome by-pass experiments
presented here show that fusion close to the nucleus leads to increased infection efficiency. Sub-
sequently at acidic pH, HA initiates fusion, reaching a maximum at pH 5 - 5.5, corresponding to
the pH of late endosomes. At this stage M1 appears monomeric and fully separated from vRNP.
The released vRNPs immediately travel into the nucleus (Bui et al., 1996).
EE
- opening of M2,
- weakening of M1-M1 
ŝŶƚĞƌĂĐƟŽŶ
ͲĨƵƐŝŽŶŝŶŝƟĂƚĞĚ
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ͲĨƵƐŝŽŶŽĨǀŝƌĂůĂŶĚ
ĞŶĚŽƐŽŵĂůŵĞŵďƌĂŶĞ
ͲǀZEWƌĞůĞĂƐĞ
pH 6-6.5 5-5.5
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pH5 by-pass
Figure 4.4: Model for the stepwise uncoating of influenza A virus (adapted from Li and Sieben et
al., submitted.)
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4.6 Conclusion and Outlook
The binding of influenza virus to red blood cells and of HA to sialic acid is known for a long
time. However, only recently many studies showed that virus-cell binding and subsequent entry
is not well understood (see section 4.3.2). It was the aim of this thesis to characterize influenza
virus-cell binding and entry in order to understand these important steps of virus infection as
well as to provide the basis for the design of virus inhibitors. Virus-cell binding was studied
using OT- and AFM-based single virus force spectroscopy (SVFS). It could be shown that the
structure of the cell surface rather than the receptor itself strongly influences receptor and cell
binding. The results reveal a new concept of virus specificity. According to this concept, virus
specificity can be investigated on different complexity levels. By choosing a specialized tech-
nique in combination with the corresponding sample preparation, receptor and cell specificities
can be studied with very high accuracy. However, as discussed above the results may not be
directly comparable. Only SVFS allows to study single virus-cell binding directly on the living
cell surface. For SVFS, it will be a future goal to use primary human lung explants or primary
cell cultures as previously shown by Weinheimer et al. (2012). In this way, different regions and
cells of the respiratory tract can be directly compared, without using model cell systems.
The obtained results were translated into the design of multivalent inhibitory nanoparticles.
These were evaluated using assays to study HA-related virus activity, such as virus-cell binding
and fusion. The inhibitory nanoparticles were shown to reduce virus activity by 80 %, leaving
only a small fraction of infective viruses. The particles were designed to mimic the host cell
surface and provide a multivalent high avidity alternative for the virus to bind. Inhibition was
shown to depend on the size of the particle and the density of functional SA residues that can
engage in virus binding. This implies that in order to find the optimal arrangement of SA on an
inhibitory particle one first has to understand the binding architecture on the host cell surface.
Atomic force in combination with super-resolution microscopy techniques can provide the basis
to characterize the ultrastructure of the cells glycocalyx. Receptor microdomains as suggested
by Nunes-Correia et al. (1999) could be identified and help to understand the signals necessary
for the virus to trigger endocytosis after binding.
The inhibitory activity of the particles could further be improved by using ligands that bind other
parts of influenza HA. Peptides or aptamers targeting the stem region could work as functional
inhibitors and prevent HAs conformational change. These ligands are also promising alterna-
tives due to their high biocompatibility without side effects as potentially produced by sialic
acid. Heterofunctionalized nanoparticles could provide increased inhibitory activity by target-
ing both influenza virus spike proteins, HA and NA. Recently, a multivalent presentation of the
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influenza NA inhibitor zanamivir was shown to block influenza virus infection in early as well
as in late stages of infection (Lee et al., 2012).
Upon Endocytosis, the virus quickly travels through the endosomal system to eventually fuse
in the perinuclear region. During this endosomal transport, the virus stabilizes the lumenal pH of
the endosome in order to delay its own fusion. Only fusion close to the nucleus allows efficient
infection. This could be shown by using specific drugs and an acid-induced by-pass of endo-
cytosis. If the viruses fail to fuse in the perinuclear region, infection is strongly reduced. The
reason for this observation remains to be investigated. One hypothesis is that premature fusion
and vRNP release lead to degradation of the viral genome and attraction of the cellular innate
immune response. Single virus tracking in combination with fluorescent labeling of NP would
allow to investigate this hypothesis by studying the lifetime of vRNPs in the cytoplasm after
fusion. In parallel, elements of the cellular immune response such as interferon induction could
be studied. In addition, the consequences of early and late fusion could be nicely investigated
using pH-stability variants of HA (Rachakonda et al., 2007) in combination with an intracellu-
lar fusion assay and infection markers. In this case the pH stability of HA can be increased or
decreased to force early or late fusion respectively.
It was further found that the virus must travel through early and late endosomes to efficiently
uncoat and deliver its genomic material. The requirement of early and late endosomal residence
was known before (Sieczkarski and Whittaker, 2003), but the sequence of the uncoating events
was only hypothesized. Here it could be shown that the direct late endosomal localization would
render the virus inactive, presumably due to aggregation of M1 with vRNPs. Hence, the virus
must travel through subacidic compartments (early endosomes). From these results a sequential
model for the uncoating of influenza virus was concluded. The model offers some possible
targets for future antiviral approaches. For example, it was shown in the present study that time
and localization of fusion are critical for the success of virus infection. Hence, interference
with endosomal acidification or transport could impede virus infection. Further, the relevance
of early endosomal compartments will be studied by using siRNA silencing of the endosomal
regulator proteins Mon1a/b. These proteins were shown to control the maturation from early
to late endosomes (Poteryaev et al., 2010) and their knock-down would allow to study early
endosomes decoupled from maturation.
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Abbreviations
AA amino acids
AFM atomic force microscopy
AFS atomic force spectroscopy
AuNP gold nanoparticle
BCA bicinchoninic acid
BD Becton Dickinson
CCP clathrin coated pit
CHO chinese hamster ovary
CME clathrin-mediated endocytosis
cryo-TEM cryogenic transmission electron microscopy
DC-SIGN dendritic cell-specific intercellular adhesion
molecule-3-grabbing non-integrin
DF degree of functionalization
DIC differential interference contrast
DMEM Dulbecco s modified eagle medium
DMSO Dimethyl sulfoxide
DPBS Dulbecco s phosphate buffered saline
EDTA Ethylenediaminetetraacetic acid
EE early endosomes
EGF epidermal growth factor
ER endoplasmic reticulum
FITC Fluoresceinisothiocyanat
FRET Foerster resonance energy transfer
GISRS Global Influenza Surveillance and Response System
HA hemagglutinin
HAI Hemagglutination inhibition assay
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
HIV human immonodeficiency virus
HRV human rhinovirus
IFN interferon
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Abbreviations
IKK2 I B kinase 2
kDa kilo Dalton
L-SIGN Liver/lymph node-specific intercellular adhesion
molecule-3-grabbing non-integrin
LE Late endosomes
MAA Maachia amurensis agglutinin
MDCK madin darby canine kidney
MES morpholineethanesulfonic acid
MVB Multivesicular bodies
MW molecular weight
NaCl natrium chloride
NF- B nuclear factor B
NIH National Institutes of Health
nm nano meter
NP nucleo protein
OT optical tweezers
PBS -/- phosphate buffered saline without CaCl and MgCl
PBS +/+ phosphate buffered saline with CaCl and MgCl
PG polyglycerol
PI Propidium iodide
pN pico newton
PNR perinuclear region
PNRC perinuclear recycling compartments
PS polystyrene
QPD quadrant photo diode
R18 octadecylrhodamine B
RBC red blood cell
RBS receptor binding site
RBS receptor binding site
Rho Rhodamine
RKI Robert Koch Institute
RT room temperature
SA sialic acid
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SDS sodium dodecyl sulfate
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis
SEM scanning electron microscopy
SL sialyllactose
SMFS single molecule force spectroscopy
SNA Sambucus nigra agglutinin
SVFS single virus force spectroscopy
TEM transmission electron microscopy
TLR Toll-like receptor
WGA wheat germ agglutinin
WHO World Health Organization
YFP yellow fluorescent protein
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